MCID: LNG028
MIFTS: 53

Long Qt Syndrome malady

Genetic diseases, Rare diseases categories

Aliases & Classifications for Long Qt Syndrome

About this section

Aliases & Descriptions for Long Qt Syndrome:

Name: Long Qt Syndrome 10 21 45 47 12 65 36
Long Q-T Syndrome 10 22 24
Romano-Ward Syndrome 10 65
 
Congenital Long Qt Syndrome 65
Lqt 10


Classifications:



External Ids:

Disease Ontology10 DOID:2843
ICD9CM29 426.82
NCIt42 C34786
MeSH36 D008133

Summaries for Long Qt Syndrome

About this section
NIH Rare Diseases:45 Long qt syndrome is a disorder of the heart’s electrical activity that can cause sudden, uncontrollable, and irregular heartbeats (arrhythmia), which may lead to sudden death. long qt syndrome can be detected by electrocardiogram (ekg). it can be caused by a variety of different gene mutations (changes). it can also be acquired (noninherited) and may be brought on by certain medicines and other medical conditions. last updated: 10/4/2013

MalaCards based summary: Long Qt Syndrome, also known as long q-t syndrome, is related to timothy syndrome and long qt syndrome 9. An important gene associated with Long Qt Syndrome is SCN5A (Sodium Channel, Voltage Gated, Type V Alpha Subunit), and among its related pathways are Interaction between L1 and Ankyrins and Cytoskeleton remodeling_RalA regulation pathway. Affiliated tissues include heart, testes and brain, and related mouse phenotypes are muscle and homeostasis/metabolism.

Disease Ontology:10 An autosomal genetic disease that is characterized by delayed repolarization of the heart following a heartbeat increases the risk of episodes of torsade de pointes (tdp, a form of irregular heartbeat that originates from the ventricles).

Wikipedia:68 Long QT syndrome (LQTS) is a rare inherited or acquired heart condition in which delayed repolarization... more...

GeneReviews summary for rws

Related Diseases for Long Qt Syndrome

About this section

Diseases in the Long Qt Syndrome family:

Long Qt Syndrome 15 Long Qt Syndrome 9
Long Qt Syndrome-3 Long Qt Syndrome-11
Long Qt Syndrome 2 Long Qt Syndrome 1
Long Qt Syndrome-10 Long Qt Syndrome 13
Long Qt Syndrome 14 Long Qt Syndrome 12
Long Qt Syndrome 6 Long Qt Syndrome 5
Familial Long Qt Syndrome

Diseases related to Long Qt Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 130)
idRelated DiseaseScoreTop Affiliating Genes
1timothy syndrome31.4CACNA1C, KCNE1, KCNQ1, SCN4B
2long qt syndrome 931.3CAV3, KCNJ2
3long qt syndrome 1531.3CALM1, CALM2, CALM3
4long qt syndrome 1431.2CALM1, CALM2, CALM3
5sudden infant death syndrome30.9CAV3, KCNE1, KCNE2, KCNH2, KCNQ1, RYR2
6long qt syndrome 130.9AKAP9, ANK2, CALM1, CALM2, CAV3, KCNE1
7jervell and lange-nielsen syndrome30.8CACNA1C, CAV3, KCNE1, KCNE2, KCNH2, KCNQ1
8long qt syndrome 210.8
9familial long qt syndrome10.8
10cardiomyopathy10.7
11brugada syndrome10.7
12long qt syndrome 1210.7
13long qt syndrome 510.7
14long qt syndrome-310.6
15long qt syndrome 1310.6
16long qt syndrome 610.6
17andersen syndrome10.6
18atrioventricular block10.6
19sudden cardiac death10.6
20syncope10.6
21congenital heart disease10.6
22scn5a-related romano ward syndrome10.6
23adult syndrome10.6
24cardiac arrhythmia, ankyrin-b-related10.6
25cardiac arrest10.6
26catecholaminergic polymorphic ventricular tachycardia10.6
27long qt syndrome-1110.5
28atrial fibrillation10.5
29long qt syndrome-1010.5
30hypertrophic cardiomyopathy10.5
31short qt syndrome10.5
32syndactyly10.5
33fainting10.5
34child syndrome10.4
35kid syndrome10.4
36coronary heart disease 310.4
37wolcott-rallison syndrome10.3
38dilated cardiomyopathy10.3
39single ventricular heart10.3
40hypokalemia10.3
41left ventricular noncompaction10.3
42sudden arrhythmia death syndrome10.3
43keratosis palmoplantaris striata10.3KCNH2, KCNJ2, KCNQ1
44nephrosclerosis10.3CALM1, CALM2
45marburg acute multiple sclerosis10.3CACNA1C, SCN5A
46ventricular fibrillation, familial, 110.3CACNA1C, SCN5A
47ventricular tachycardia, catecholaminergic polymorphic, 110.3ANK2, CALM1, RYR2
48bleeding disorder, platelet-type, 1510.3CALM1, CALM2, CALM3
49otosalpingitis10.3CALM1, CALM2
50hypertrichosis terminalis, generalized, with or without gingival hyperplasia10.3KCNE2, KCNH2, KCNJ2, KCNJ5

Graphical network of the top 20 diseases related to Long Qt Syndrome:



Diseases related to long qt syndrome

Symptoms for Long Qt Syndrome

About this section

Drugs & Therapeutics for Long Qt Syndrome

About this section

Drugs for Long Qt Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 88)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
GuaifenesinapprovedPhase 4, Phase 149693-14-13516
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
7 Select Mucus Relief
Actifed C
Adult Tussin
Adult Tussin chest congestion
Aeronesin
Air Power
Amonidren
Amonidrin
Aresol
Benylin-E
Bidex-400
Bronchol
Broncomar SF
Careone Adult Tussin
Careone Mucus Er
Careone Mucus Relief childrens
Chest Congestion
Chest Congestion Relief
Chest Congestion childrens
Childrens Chest Congestion
Childrens Chest Congestion Relief
Childrens Mucinex Chest Congestion
Childrens Mucinex Mini-Melts Chest Congestion
Childrens Mucus Relief
Childrens Mucus Relief Expectorant Grape
Childrensrelief Expectorant Grape
Cough
Cough Out
Dg Health Mucus Relief Er
Diabetic Siltussin Das-na
Diabetic Tussin Expectorant
Diabetic Tussin Mucus Relief
Equaline Mucus Er
Equaline Tussin chest congestion
Equate Mucus Er
Equate Tussin Adult Chest Congestion
Expectorant
Expectorant 12 Hour
Gadavyt Cough
Geri-tussin Expectorant
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
Good Neighbor Pharmacy Mucus Er
Good Neighbor Pharmacy Mucus Relief
Good Neighbor Pharmacy Tabtussin
Good Neighbor Pharmacy Tussin
Good Sense Mucus Er
Good Sense Mucus Relief
Good Sense Tussin chest congestion
Guaap
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesin Extended Release
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphesin
Guiatuss
Health Mart Adult Tussin
Health Mart Mucus Er
Healthmart Chest Congestion Relief
Healthy Accents Childrens Mucus Relief
Healthy Accents Mucus Relief
Healthy Accents Tussin
Healthy Accents Tussin Chest Congestion adult
Hustosil
 
Iophen Nr
Kids-eeze Chest Relief
Leader Adult Tussin Chest Congestion
Leader Adult Tussin Mucus Plus Chest Congestion
Leader Chest Congestion Relief G450
Leader Cough Tabs
Leader Mucus Er
Leader Mucus Relief childrens
Leader Tabtussin 400
Licorice Coughing Liquid
Liqufruta
Liquituss Gg
Little Remedies Little Colds Mucus Relief Expectorant Melt Aways
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
Mucaplex
Mucinex
Mucinex For Kids
Mucinex Maximum Strength
Mucinex for Kids
Mucosa
Mucus Er
Mucus Extended Release
Mucus Releif Expectorant
Mucus Relief
Mucus Relief Chest
Mucus Relief Er
Mucus Relief Expectorant
Mucus Relief Immediate Release
O-Methoxyphenyl glyceryl ether
Organ-i Nr
Organidin NR
Pancold S
Pneumomist
Preferred Plus Chest Congestion Relief
Preferred Plus Mucus Er
Preferred Plus Tabtussin
Premier Value Chest Congestion Relief
Propanosedyl
Q-tussin
Qtussin
Quality Choice Mucus Relief
Reduton
Refenesen
Refenesen Chest Congestion Relief
Respaire-30
Ritussin Expectorant
Robafen Cough Formula
Robitussin
Robitussin Mucus Plus Chest Congestion
Rompe Pecho
Rompe Pecho EX
Rompe Pecho SF
Rugby Mucus Er
Rx Act Tussin Chest Congestion
Scot-tussin Expectorant Sf Cough
Select Brand Coughtab 400
Select Brand Mucus Relief
Select Brand Tab Tussin
Selecthealth Tussin Dm
Shopko Chest Congestion Relief
Shoprite Adult Tussin
Shoprite Mucus Relief
Siltussin Das
Siltussin Sa
Simpex Guaifenesin
Simply Right Mucus Relief
Smart Sense Childrens Mucus Relief
Smart Sense Mucus Er
Smart Sense Tussin adult
Sunmark Mucus Er
Sunmark Tussin
Sunmark Tussin chest congestion
The Medicine Shoppe Chest Congestion Relief
Topcare Mucus Er
Topcare Mucus Relief
Topcare Tussin Chest Congestion
Topcare Tussin mucus plus chest congestion
Tussin
Tussin Adult chest congestion
Tussin Chest
Tussin Chest Congestion Adult Non Drowsy
Tussin Chest Congestion Non Drowsy
Tussin EXPECTORANT
Tussin Non Drowsy
Tussin Original
Tussin adult chest congestion
Tussin adults non drowsy
Tussin expectorant for adults
Tussin mucus plus chest congestion
Ultra Tuss
Wal Tussin adult chest congestion
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
guaiphenesin
p-Cresyl acetate
2
Ethinyl EstradiolapprovedPhase 4, Phase 2, Phase 3, Phase 163657-63-65991
Synonyms:
17 alpha-Ethinylestradiol
17 alpha-Ethynylestradiol
17 alpha-Ethynyloestradiol
17 alpha-ethinyestradiol
17-Ethinyl-3,17-estradiol
17-Ethinyl-3,17-oestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17-alpha-Ethinyl-17-beta-estradiol
17-alpha-Ethynyl-17-beta-oestradiol
17-alpha-Ethynylestradiol
17-alpha-Ethynylestradiol-17-beta
17-alpha-ethynyl estradiol
17-ethinyl-3,17-estradiol
17-ethinyl-3,17-oestradiol
17-ethinylestradiol
17.alpha.-Ethinyl-17.beta.-estradiol
17.alpha.-Ethinylestradiol
17.alpha.-Ethynyl-17.beta.-oestradiol
17.alpha.-Ethynylestradiol
17.alpha.-Ethynylestradiol-l7.beta.
17.alpha.-Ethynyloestradiol
17.alpha.-Ethynyloestradiol-17.beta.
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol
17a-Ethynylestradiol-l7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17alpha-Ethinylestradiol
17alpha-Ethinylestradiol-17beta
17alpha-Ethynylestradiol
17alpha-Ethynyloestradiol
17alpha-Ethynyloestradiol-17beta
17α-ethynylestradiol
406932-93-2
46263_FLUKA
46263_RIEDEL
57-63-6
77538-56-8
AC-2169
AC1L1LK6
AI3-52941
Aethinyloestradiolum
Aethinyoestradiol
Aethinyoestradiol [German]
Alora
Amenoron
Amenorone
Anovlar
BIDD:ER0162
BRN 2419975
Bio-0610
C07534
CCRIS 286
CHEBI:4903
CHEMBL691
CID5991
CPD000058319
Certostat
Chee-O-Gen
Chee-O-Genf
Cyclosa
D004997
D00554
DB00977
Dicromil
Diognat-E
Diogyn E
Diogyn-E
Diprol
Dyloform
E4876_SIGMA
EE
EE(sub 2)
EE2
EINECS 200-342-2
EO
ETHINYLESTRADIOL
Effik Brand of Ethinyl Estradiol
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Estinyl (TN)
Eston-E
Estopherol
Estoral
Estoral (Orion)
Estoral (VAN)
Estoral [Orion]
Estoral {[Orion]}
Estorals
Estradiol, Ethinyl
Estradiol, Ethynyl
Estring
Estrogen
Ethidol
Ethinoral
Ethinyl E2
Ethinyl Estradiol Hemihydrate
Ethinyl Estradiol [USP]
 
Ethinyl Estradiol, (8 alpha)-Isomer
Ethinyl Oestradiol Effik
Ethinyl estradiol
Ethinyl estradiol (USP)
Ethinyl-Oestradiol Effik
Ethinyl-Oestranol
Ethinyl-oestranol
Ethinylestradiol
Ethinylestradiol (JP15/INN)
Ethinylestradiol Jenapharm
Ethinylestradiol [INN:BAN:JAN]
Ethinylestradiolum
Ethinylestradiolum [INN-Latin]
Ethinylestriol
Ethinyloestradiol
Ethinyloestradiol [Steroidal oestrogens]
Ethy 11
Ethynyl estradiol
Ethynylestradiol
Ethynylestradiol, Ethinyl Estradiol
Ethynyloestradiol
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
Etinilestradiol
Etinilestradiol [INN-Spanish]
Etinilestradiolo
Etinilestradiolo [DCIT]
Etinoestryl
Etistradiol
Etivex
Evra
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
HMS2051I19
HSDB 3587
Halodrin
Hemihydrate, Ethinyl Estradiol
Inestra
Innofem
Jenapharm Brand of Ethinyl Estradiol
Jenapharm, Ethinylestradiol
Kolpolyn
LMST02010036
LS-231
Linoral
Lynoral
MLS000028479
MLS000758274
Marvelon
Menolyn
Menostar
Mercilon
Microfollin
Microfollin Forte
MolPort-001-794-636
NCGC00091533-01
NCGC00091533-04
NCGC00091533-05
NCI60_000234
NSC-10973
NSC10973
Neo-Estrone
Nogest-S
Novestrol
OVULEN-21
OVULEN-28
Oradiol
Orestralyn
Orestrayln
Organon Brand of Ethinyl Estradiol
Ortho-Cyclen
Ovex
Oviol
PUBERTAL ETHINYL ESTRADIOL STUDY
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn M
Progynon C
Progynon M
Prosexol
S1625_Selleck
SAM001247008
SGCUT00127
SMR000058319
Schering Brand of Ethinyl Estradiol
Spanestrin
Thiuram E
Thiuranide
UNII-423D2T571U
Vagifem
Varnoline
WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ
Ylestrol
component of Demulen
component of Oracon
component of Ortrel
ethinyl estradiol
ethynyl estradiol
to_000048
3
Moxifloxacinapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 1394354812-41-2152946
Synonyms:
(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid
151096-09-2
186826-86-8
192927-63-2
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
AC1L49EP
Actira (*Hydrochloride*)
Avelox
Avelox (*Hydrochloride*)
Avelox I.V.
BAY 12-8039
BAY 12-8039 (*Hydrochloride*)
 
CCRIS 8690
CHEMBL32
CID152946
DB00218
I06-1961
LS-141510
MFX
MXF
MXFX
Moxeza
Moxifloxacin
Moxifloxacin Hydrochloride
Moxifloxacin [INN:BAN]
UNII-U188XYD42P
Vigamox
moxifloxacin
4
NorgestimateapprovedPhase 4, Phase 2, Phase 3, Phase 133935189-28-76540478
Synonyms:
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)
(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime
(3E)-17alpha-ethynyl-3-(hydroxyimino)-18a-homoestr-4-en-17beta-yl acetate
35189-28-7
AC-655
AC1O712U
C017576
CHEBI:50815
CHEMBL1200934
CID6540478
D 138
D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
D05209
DB00957
Dexnorgestrel Acetime
Dexnorgestrel acetime
I14-9729
 
LS-62080
NCGC00181353-01
NORGESTIMATE
Norgestimate (USP/INN)
Norgestimate [USAN:INN:BAN]
Norgestimato
Norgestimato [INN-Spanish]
Norgestimatum
Norgestimatum [INN-Latin]
ORF 10131
ORF-10131
Ortho-Prefest
RWJ 10131
RWJ-10131
UNII-C291HFX4DY
ZINC03938695
[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
d-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime
d-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime
norgestrel oxime acetate
5
MethadoneapprovedPhase 4, Phase 129676-99-34095
Synonyms:
(+)-Methadone
(+-)-Methadone
(+/-)-Methadone
(+/-)-Methadone hydrochloride
(+/-)-Tussal
(-)-(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(-)-Methadone
(6R)-Methadone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(R)-6-(Dimethylamino)-4,4-diphenyl-3-hetpanone
(S)-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
(±)-methadone
1095-90-5 (hydrochloride)
297-88-1
3-14-00-00278 (Beilstein Handbook Reference)
3-14-00-00279 (Beilstein Handbook Reference)
3-Hetpanone, 6-(dimethylamino)-4,4-diphenyl-, (R)- (9CI)
5653-80-5
6-(Dimethylamino)-4,4-diphenyl-3-heptanone dl-mixture
6-(dimethylamino)-4,4-diphenylheptan-3-one
6-Dimethylamino-4,4-diphenyl-3-heptanone
6-dimethylamino-4,4-di(phenyl)heptan-3-one
6S-Methadone
76-99-3
A 4624
AC-16055
AC1L1HEG
AC1Q2RLW
AN 148
AN-148 (*Hydrochloride*)
Adanon
Adanon hydrochloride
Adolan
Algidon
Algolysin
Algovetin
Althose
Althose hydrochloride
Amidon
Amidone
BRN 3213667
BRN 3213668
BRN 3213669
Biscuits
Butalgin
C07163
CHEBI:6807
CHEMBL651
CID4095
D08195
DB00333
DEA No. 9250
DL-Methadone hydrochloride
Depridol
Dextromethadone
Diaminon
Diaminon hydrochloride
Diskets
DivK1c_000963
Dl-Methadone
Dollies
Dolly
Dolofin hydrochloride
Dolohepton
Dolophin
Dolophin hydrochloride
Dolophine
Dolophine (*Hydrochloride*)
Dolophine HCL
EINECS 200-996-9
Fenadon
Fenadone
 
Fenadone (*Hydrochloride*)
HSDB 3119
Heptadon
Heptadone
Heptadone (*Hydrochloride*)
Heptanon
Heptanon (*Hydrochloride*)
Heptanon (pharmaceutical)
Hoechst 10820
Hoescht 10820 (*Hydrochloride*)
IDI1_000963
K 174
KBio1_000963
Ketalgin
Ketalgin hydrochloride
L-(+)-Methadone
L-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
L-Polamidon
L000874
LS-74485
LS-74486
LS-74487
Levometadona
Levometadona [INN-Spanish]
Levomethadone [INN]
Levomethadonum
Levomethadonum [INN-Latin]
Levothyl
Mecodin
Mephenon
Metadona
Metadona [INN-Spanish]
Metadona [Spanish]
Metadone
Metadone [DCIT]
Metasedin
Methadon
Methadona
Methadona [Spanish]
Methadone (BAN)
Methadone HCL
Methadone HCL Intensol
Methadone Hydrochloride
Methadone M
Methadone [INN:BAN]
Methadone hydrochloride
Methadonum
Methadonum [INN-Latin]
Methadonum [Latin]
Methadose
Methaquaione
Miadone
Moheptan
MolPort-001-785-650
NINDS_000963
Phenadone
Phenadone (*Hydrochloride*)
Phenadone hydrochloride
Physeptone
Polamidon
Polamidone
Polamivet
Racemic methadone
S-(+)-Methadone
Sedo-Rapide
Tussol
UNII-UC6VBE7V1Z
Westadone
d-6-(Dimethylamino)-4,4-diphenyl-3-heptanone
d-Methadone
dl-Methadone
l-Methadone
l-Polamivet
methadone
6
Estradiolapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 1105750-28-25757, 53477783
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate
1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17-.BETA.-Estradiol
17-E
17-beta
17-beta-OH-estradiol
17-beta-estradiol
17.beta.-Estradiol
17.beta.-Oestradiol
17E
17b-Estradiol
17b-Oestradiol
17beta Oestradiol
17beta oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17beta-Estradiol
17beta-Oestradiol
1jgl
1qkt
1qku
2d06
3,17-Epidihydroxyestratriene
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
B-Estradiol
BEDOs
BIDD:ER0125
BIDD:PXR0065
BPBio1_000532
BSPBio_000482
BSPBio_001065
Bardiol
Benzhormovarine
Beta-estradiol
Bio-0812
Bio-E-Gel
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
CMC_11154
CPD-352
CPD000059126
Climaderm
Climara
Climara (TN)
Climara Forte
Compudose
Compudose 200
Compudose 365
Corpagen
D-3,17beta-Estradiol
D-Estradiol
D-Oestradiol
D00105
DB00783
Depo-estradiol
Dermestril
Destradiol
Dihydro-Theelin
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
EU-0100503
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
Estradiol
Estradiol Transdermal System
Estradiol Valerate
Estradiol [USAN:INN]
Estradiol acetate
Estradiol benzoate
Estradiol cypionate
Estradiol valerate
Estradiol-17 beta
Estradiol-17-beta
Estradiol-17.beta.
Estradiol-17beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring Vaginal Ring
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
 
Estrofem Forte
Estrogel
Estrogel (TN)
Estrogel HBF
Estrovite
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femring
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
GynPolar
Gynergon
Gynestrel
Gynodiol
Gynoestryl
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
LMST02010001
LS-137
Lamdiol
Lio-Oid
Lopac0_000503
MLS000069494
MLS000758312
MLS001076331
Macrodiol
Macrol
Menest
Menorest
Menostar
Microdiol
Minivelle
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
NSC-9895
NSC9895
Nordicol
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17-beta
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Prestwick_207
Primofol
Profoliol
Profoliol B
Progynon
Progynon DH
Progynon-DH
S-21400
S1709_Selleck
SAM001247032
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Sandrena 1
Sandrena Gel
Sisare Gel
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
VIVELLE-DOT
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
Vivelle Dot
Vivelle-dot
Zerella
Zesteem
Zesteen
Zumenon
[2,4,6,7-3H]-E2
[3H]-estradiol
[3H]]estradiol
b-Estradiol
beta-Estradiol
beta-Estradiol 3-sulfate
beta-Estradiol 3-sulphate
bmse000642
cMAP_000005
cis-Estradiol
cis-Oestradiol
component of Menrium
delta-Estradiol
delta-Oestradiol
estradiol
estradiol-17beta
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
progynon
7
LithiumapprovedPhase 42067439-93-228486
Synonyms:
159577-72-7
201049_ALDRICH
207241_ALDRICH
207241_FLUKA
220914_ALDRICH
248827_ALDRICH
265969_ALDRICH
265977_ALDRICH
265985_ALDRICH
265993_ALDRICH
266000_ALDRICH
278327_ALDRICH
320080_ALDRICH
340421_ALDRICH
3Li
444456_ALDRICH
499811_ALDRICH
62500_FLUKA
64975-42-4
7439-93-2
7580-67-8
AB1003835
AC1MHL68
C15473
CHEBI:30145
CID3028194
D008094
D08133
EINECS 231-102-5
EINECS 231-484-3
Eskalith
HSD690000
HSDB 549
HSDB 647
HSDB 6900
Hydrure de lithium [French]
LITHIUM
LITHIUM HYDRIDE
 
LITHIUM HYDRIDE, 98.6%
LITHIUM ion
LS-88055
LS-88066
LTBB002851
Li
Li(+)
Li(+) cation
Li(+) ion
Lithium
Lithium Carbonate
Lithium [UN1415] [Dangerous when wet]
Lithium [UN1415] [Dangerous when wet]
Lithium atom
Lithium atomic absorption standard solution
Lithium carbonate
Lithium cation
Lithium compounds
Lithium element
Lithium hydride (LiH)
Lithium hydride [UN1414] [Dangerous when wet]
Lithium hydride [UN1414] [Dangerous when wet]
Lithium hydride, fused solid [UN2805] [Dangerous when wet]
Lithium hydride, fused solid [UN2805] [Dangerous when wet]
Lithium monohydride
Lithium, elemental
Lithium, ion
Lithium, ion (li1+)
Lithium, metallic
Lithium-6Li
LithoTab
Lithobid
MolPort-003-926-239
MolPort-003-927-072
Normothymin-E
Normothymin-E (TN)
UN1414
UN1415
UN2805
litio
8
Aripiprazoleapproved, investigationalPhase 4, Phase 2331129722-12-960795
Synonyms:
129722-12-9
24-29-3
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one
AC-1554
AC1L1TXZ
AC1Q3T38
ALKS-9070
Abilify
Abilify (TN)
Abilify DISCMELT
Abilify Discmelt
Abilify Maintena
Abilitat
Aripiprazol
Aripiprazole
Aripiprazole (JAN/USAN/INN)
Aripiprazole [USAN]
Aripiprazolum
Aripirazole
Arpizol
Asprito|
BMS-337039
Bio-0004
Bristol-Myers Squibb brand of aripiprazole
C094645
C12564
C23H27Cl2N3O2
CHEBI:31236
CHEMBL1112
CID60795
 
CPD000466383
D01164
DB01238
Discmelt
FT-0082572
HMS2051I18
HMS2089M20
HMS2093F22
HSDB 7320
KS-1030
L001339
LS-142666
MLS000759517
MLS001165779
MLS001195621
MLS001424078
MolPort-002-885-808
MolPort-003-844-657
NCGC00159510-02
NCGC00159510-03
OPC 31
OPC-14597
OPC-31
Opc 14597
Otsuka brand of aripiprazole
Pripiprazole
S06-0010
SAM001246750
SMR000466383
STK625160
TL8000707
TL80090184
UNII-82VFR53I78
aripiprazol
aripiprazole
aripiprazolum
||OPC 14597
9
Valproic Acidapproved, investigationalPhase 430299-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-PROPYL-pentanoic acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Depakote ER
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VALPROIC acid
VPA
Valcote
Valparin
Valproate
Valproate Semisodium
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic
Valproic Acid
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
10
RifampinapprovedPhase 429013292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin sv
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicin sodium
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin
11Chlorpheniramine, phenylpropanolamine drug combinationPhase 4, Phase 1496
12Norgestimate, ethinyl estradiol drug combinationPhase 4, Phase 2, Phase 3, Phase 1394
13Polyestradiol phosphatePhase 4, Phase 2, Phase 3, Phase 11057
14Estradiol 17 beta-cypionatePhase 4, Phase 2, Phase 3, Phase 11083
15Contraceptives, Oral, CombinedPhase 4, Phase 2, Phase 3, Phase 1548
16Lithium CarbonatePhase 4206
17Estradiol 3-benzoatePhase 4, Phase 2, Phase 3, Phase 11057
18Estradiol valeratePhase 4, Phase 2, Phase 3, Phase 11057979-32-8
19
CorticosteronePhase 4950-22-65753
Synonyms:
11,21-Dihydroxypregn-4-ene-3,20-dione
11,21-Dihydroxyprogesterone
11-Hydroxycorticoaldosterone
 
17-Deoxycortisol
4-Pregnene-11 Corticosteron
Corticosterone
Kendall'S compound B
Reichstein'S substance H
20Fluorodeoxyglucose F18Phase 4340
21
Linezolidapproved, investigationalPhase 2, Phase 399165800-03-3441401
Synonyms:
(S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
111GE017
165800-03-3
AC-16128
AC1L9B3M
BIDD:GT0404
C08146
C16H20FN3O4
CHEBI:126280
CHEMBL126
CID441401
CPD000466335
D00947
DB00601
DB08769
FT-0080803
HMS2051F08
HMS2089K06
HSDB 7478
LS-173594
Linezlid
Linezolid
Linezolid & VRC3375
Linezolid (JAN/USAN/INN)
Linezolid [USAN:INN]
Linezolide
 
Linezolidum
MLS000759444
MLS001424075
MolPort-003-986-503
N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
N-({5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
NDA 21-130 Zyvox (linezolid tablets)
NDA 21-131 Zyvox for injection (linezolid injection)
NDA 21-132 Zyvox oral suspension (linzolid oral suspension)
PNU 100766
PNU-100766
PNU-100766, U-100766, Zyvoxid, Zyvoxam, Linezolid
S1408_Selleck
SAM001246624
SMR000466335
TL8001272
U 100766
U-100766
ZINC02008866
ZLD
Zyvox
Zyvox (TN)
Zyvoxa
Zyvoxam
Zyvoxid
linezolid
22
BedaquilineapprovedPhase 2, Phase 326843663-66-1
Synonyms:
1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol
Bedaquilina
Bedaquiline Fumarate
Bedaquilinum
 
R 207910
R207910
Sirturo
TMC 207
TMC-207
TMC207
23
Clofazimineapproved, investigationalPhase 2, Phase 3192030-63-92794
Synonyms:
(3Z)-N,5-bis(4-chlorophenyl)-3-[(1-methylethyl)imino]-3,5-dihydrophenazin-2-amine
2030-63-9
3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine
3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin
3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin [German]
3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine
4-25-00-03033 (Beilstein Handbook Reference)
AC1L1EHE
B 663
B 663 (Pharmaceutical)
B 663 (VAN)
B 663, pharmaceutical
B-663
B. 663
B663
BIDD:PXR0147
BPBio1_000585
BRN 0060420
BSPBio_000531
C06915
C27H22Cl2N4
C8895_SIGMA
CAS-2030-63-9
CFZ
CHEBI:3749
CHEBI:730395
CHEMBL1083384
CHEMBL1292
CID2794
CPD000058704
Chlofazimine
Clofazimin
Clofazimina
Clofazimina [INN-Spanish]
Clofazimine
Clofazimine (JAN/USP/INN)
Clofazimine [USAN:INN:BAN]
Clofaziminum
Clofaziminum [INN-Latin]
 
D00278
DB00845
EINECS 217-980-2
G 30320
G-30,320
G-30320
HMS1569K13
HMS2052B05
HMS2093J10
I06-1891
LS-103014
Lampren
Lamprene
Lamprene (TN)
Liposome-encapsulated clofazimine
MLS000028617
MLS001424318
N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(1-methylethyl)imino)-2-phenazinamine
N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-(isopropylimino)phenazin-2-amine
N,5-Bis(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-2-phenazinamine
N,5-bis(4-chlorophenyl)-3-(propan-2-ylimino)-3,5-dihydrophenazin-2-amine
N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine
NCGC00016600-01
NCGC00016600-02
NCGC00179529-01
NSC 141046
NSC-141046
NSC141046
Prestwick0_000376
Prestwick1_000376
Prestwick2_000376
Prestwick3_000376
Prestwick_685
Riminophenazine
SAM001246878
SMP2_000339
SMR000058704
SPBio_002452
ST51014966
UNII-D959AE5USF
clofazimine
24DiarylquinolinesPhase 2, Phase 35
25
Risperidoneapproved, investigationalPhase 2579106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
NCGC00015883-01
 
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperdal M-tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone M-tab
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
26
AzithromycinapprovedPhase 230983905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
27
Olanzapineapproved, investigationalPhase 2369132539-06-14585
Synonyms:
132539-06-1
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC-665
AC1L1IHS
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
LS-152313
LY 170053
LY-170052
LY-170053
 
Lanzac
Lilly brand of olanzapine
MLS000759457
MLS001165781
MLS001195646
MLS001424057
Midax
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
Olanzapina
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
Olanzapine pamoate
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa Zydis
olanzapina
olanzapine
olanzapinum
28
ErythromycinapprovedPhase 2, Phase 185114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E.e.s
E.e.s.
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Ery-ped
Ery-tab
Eryacne
Eryacnen
Erybid
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythra-derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
 
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin Base
Erythromycin Base Base
Erythromycin Base Filmtab
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
29
DopamineapprovedPhase 2, Phase 1281462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
30
IbutilideapprovedPhase 25122647-32-960753
Synonyms:
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfoanilide (E)-2-butenedioate (2:1)
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide fumarate (2:1) (salt)
(+-)-N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide (E)-butenedioate
(E)-but-2-enedioic acid
122647-31-8
122647-31-8 (Parent)
122647-32-9
122647-32-9 (Fumarate)
130350-52-6
2C20H36N2O3S.C4H4O4
AC1L1TUW
AC1NQXZ2
AC1O5NJM
AC1Q6VUF
Butilide fumarate
C07753
C20H36N2O3S
CHEBI:112608
CHEMBL1200564
CHEMBL533
CID5281065
CID60753
CID6437366
Corvert
Corvert (TN)
D00648
D08060
DB00308
I06-1701
IBUTILIDE FUMARATE
Ibutilid
 
Ibutilida
Ibutilida [INN-Spanish]
Ibutilide
Ibutilide (INN)
Ibutilide Fumarate
Ibutilide Fumarate [USAN]
Ibutilide [BAN:INN]
Ibutilide [INN:BAN]
Ibutilide fumarate (USAN)
Ibutilidum
Ibutilidum [INN-Latin]
LS-172765
LS-90123
LS-90124
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-, (E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-,(E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (E)-2-butenedioate (2:1) (salt)
MolPort-005-932-621
N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide
N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
NCGC00181771-01
U 70226E
U-70226E
U-82208E
U-82209E
U82208E
U82209E
UNII-2436VX1U9B
UNII-9L5X4M5L6I
ibutilide, (+-)-isomer
ibutilide, fumarate salt (2:1), (+-)-isomer
n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
31
ProgesteroneapprovedPhase 247357-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
32
Ranolazineapproved, investigationalPhase 274142387-99-356959
Synonyms:
( -)-Ranolazine
(-)-Ranolazine
142387-99-3
95635-55-5
AC-1673
AC1L1M17
AC1Q5LYD
BRD-A97674275-001-01-9
BSPBio_002276
CHEMBL1404
CID56959
CVT-303
D05700
DB00243
HMS1922F16
HMS2090L09
HMS2093D21
I01-2008
I06-0160
KEG-1295
LS-187267
Latixa
Lopac0_001062
 
MLS002154149
MolPort-003-666-653
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
NCGC00015897-05
NCGC00095177-01
NCGC00095177-02
NCGC00095177-03
RAN D
RANOLAZINE
RS-43285
RS-43285-003
Ran4
Ranexa
Ranexa (TN)
Ranexa, Ranolazine
Ranolazine (USAN/INN)
Ranolazine 2HCl
Ranolazine Dihydrochloride
Ranolazine dihydrochloride
S1799_Selleck
SMR000857382
SPECTRUM1505366
UNII-A6IEZ5M406
ranolazine
33Erythromycin EstolatePhase 2, Phase 185
34Erythromycin EthylsuccinatePhase 2, Phase 185
35Erythromycin stearatePhase 2, Phase 185
36ProgestinsPhase 2408
37
SerotoninPhase 2, Phase 1285350-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
38
QuinineapprovedPhase 138130-95-08549, 3034034
Synonyms:
(+)-Quinidine
(-)-Quinine
(1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol
(3|A,8|A,9r)-6'-methoxycinchonan-9-ol
(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol
(8-alpha,9R)-6'-Methoxycinchonan-9-ol
(8.alpha.,9R)-6'-Methoxycinchonan-9-ol
(8S,9R)-6'-Methoxycinchonan-9-ol
(8S,9R)-Quinine
(9R)-6'-methoxy-8alpha-cinchonan-9-ol
(R)-(-)-Quinine
(R)-(-)-Quinine, 6-methoxycinchonidine
(R)-(-)-quinine
(R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol
(S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
.alpha.-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol
12239-42-8
128544-03-6
130-89-2
130-95-0
1407-83-6
145904_ALDRICH
21480-31-9
22620_FLUKA
22620_SIGMA
549-56-4
55980-20-6
56-54-2
6'-Methoxycinchonan-9-ol
6'-Methoxycinchonidine
6'-Methoxycinchonine
6-Methoxycinchonine
6119-70-6
6183-68-2
6912-57-8
72646-90-3
767303-40-2
804-63-7
840482-04-4
857212-53-4
864908-93-0
875538-34-4
888714-03-2
890027-24-4
894767-09-0
898813-59-7
898814-28-3
899813-83-3
900786-66-5
900789-95-9
906550-97-8
909263-47-4
909767-48-2
909882-78-6
910878-25-0
910880-97-6
911445-75-5
918778-04-8
AC1L1ANE
AC1L1R7Y
AC1L9AHT
AC1LCUGN
AC1MHWS7
AC1MI1Q5
AC1Q4EZ5
AC1Q58AF
AR-1A4833
AR-1H2065
Aflukin
BB_NC-0697
Biquinate (*Bisulfate heptathydrate*)
C06526
C20H24N2O2
CCRIS 5755
CHEBI:111177
CHEBI:15854
CHEMBL170
CHEMBL97
CID1065
CID3034034
CID3036746
CID441073
CID637552
CID8549
Chinin
 
Chinin [German]
Chinine
Chininum
Cin-Quin
Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate
Coco-Quinine
Conchinin
Conquinine
D08460
DB00468
Dentojel (*Bisulfate heptathydrate*)
EINECS 205-003-2
EINECS 215-805-4
HMS1607A11
HMS1791J11
HMS2089E05
HSDB 2501
I14-3348
I14-3397
IBS-L0034250
InChI=1/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H
KST-1A1085
Kinder Quinina
Kinder Quinina (TN)
L001278
LS-141252
LS-194958
LS-4562
LT00645788
Lopac0_001029
MLS001304041
MolPort-000-146-082
MolPort-001-766-747
MolPort-002-507-196
MolPort-003-901-021
NCGC00015871-03
NCGC00142453-01
NCGC00159499-02
NCGC00159499-03
NCGC00162322-01
NCGC00162322-02
NCGC00163142-03
NCGC00166281-01
NCI60_004320
NSC 192949
NSC 5362
NSC131458
NSC192949
NSC5362
NSC667852
Q0028
QUININE MONO HCL
Qualaquin
Quinamm (*2:1 Sulfate salt*), dihydrate
Quindan
Quine (*2:1 Sulfate salt*, dihydrate)
Quinidex
Quinimax
Quinina
Quinine
Quinine (BAN)
Quinine Dab
Quinine Hydrochloride
Quinine Sulfate
Quinine [BAN]
Quinine anhydrous
Quinine bisulfate
Quinine sulfate
Quinine sulphate
Quinine, Anhydrous
Quinine, polymers
Quinine, tannate
Quinineanhydrous
Quinoline Alkaloid
Quinoline alkaloid
Quinora
Quinsan (*2:1 Sulfate salt*), dihydrate
Quniacridine
SB01652
SMR000718748
ST056282
UNII-A7V27PHC7A
WLN: T66 BNJ HO1 EYQ-DT66 A B CNTJ A1U1
beta-Quinine
chininum
nchem.1039-compI
nchem.180-comp1a
nchembio.215-comp5
nchembio.368-comp9
nchembio.87-comp19
quinidine
quinina
quinine sulfate
39
ZincapprovedPhase 114047440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
40
OxymetazolineapprovedPhase 13851491-59-44636
Synonyms:
1491-59-4
2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol
3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
AC-6370
AC1L1IM1
Afrin Cherry 12 Hour Nasal Spray
Afrin Extra Moisturizing 12 Hour Nasal Spray
Afrin Original 12 Hour Nasal Spray
Afrin Original 12 Hour Nose Drops
Afrin Original 12 Hour Pump Mist
Afrin Sinus 12 Hour Nasal Spray
BPBio1_000295
BPBio1_000419
BRD-K16195444-001-01-7
BRN 0886303
BSPBio_000267
BSPBio_002145
Biomol-NT_000161
C07363
CAS-151615
CHEBI:142520
CHEMBL762
CID4636
D010109
D08322
DB00935
DivK1c_000567
Dristan Long Lasting Mentholated Nasal Spray
Dristan Long Lasting Nasal Mist
Drixoral Nasal Solution
Duramist Plus Up To 12 Hour Nasal Decongestant Spray
EINECS 216-079-1
FT-0082560
Genasal Nasal Spray Up to 12 Hour Relief
H 990
HMS2089G03
HSDB 3143
Hazol
IDI1_000567
Iliadin
KBio1_000567
KBio2_001531
KBio2_004099
KBio2_006667
KBio3_001645
KBioGR_000908
KBioSS_001531
L000459
LS-104146
Lopac-O-2378
Lopac0_000903
 
MolPort-002-538-313
Mucinex Full Force
Mucinex Moisture Smart
NCGC00015766-01
NCGC00015766-02
NCGC00015766-03
NCGC00015766-10
NCGC00022345-02
NCGC00022345-04
NCGC00022345-05
NCGC00022345-06
NINDS_000567
Nafrine
Nasal Relief 12 Hour Nasal Spray
Navasin
Navisin
Neo-Synephrine 12 Hour Spray
Nezeril
Nostrilla 12 Hour Nasal Decongestant
Operil (TN)
Oximetazolina
Oximetazolina [INN-Spanish]
Oximetazolinum
Oxylazine
Oxymetazolina
Oxymetazoline (INN)
Oxymetazoline Hydrochloride
Oxymetazoline [INN:BAN]
Oxymetazoline hydrochloride
Oxymetazoline hydrochloride crystalline
Oxymetazolinum
Oxymetazolinum [INN-Latin]
Oxymethazoline
Oxymetozoline
Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl- (9CI)
Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl- (7CI,8CI)
Prestwick0_000224
Prestwick1_000224
Prestwick2_000224
Prestwick3_000224
Rhinofrenol
Rhinolitan
SPBio_001095
SPBio_002188
Sinerol
Spectrum2_000998
Spectrum3_000533
Spectrum4_000464
Spectrum5_001114
Spectrum_001051
Tocris-1142
UNII-8VLN5B44ZY
Vicks Sinex 12 Hour Nasal Spray
Vicks Sinex 12 Hour Ultra Fine Mist for Sinus Relief
Visine L.R
Visine L.R.
nchembio705-11
oxymeta zoline
oxymetazoline
oxymetazoline hydrochloride crystalline
41
LoxapineapprovedPhase 1271977-10-23964
Synonyms:
1977-10-2
2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine
2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine
2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine
27833-64-3 (succinate)
54810-23-0 (mono-hydrochloride)
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine
AC1L1H3Z
AC1Q3ZWR
Adasuve
BPBio1_000226
BRD-K39915878-036-04-6
BRD-K39915878-036-05-3
BRN 0626753
BSPBio_000204
BSPBio_003479
C07104
C18H18ClN3O
CHEBI:50841
CHEMBL831
CID3964
CL 62362
CL-62362
CL-71,563
Cloxazepine
D02340
DB00408
Dibenzacepin
Dibenzoazepine
DivK1c_006919
EINECS 217-835-3
HF 3170
HF3170
HSDB 3111
Hydrofluoride 3170
KBio1_001863
KBio2_000835
KBio2_003403
KBio2_005971
KBio3_002983
KBioSS_000835
L001085
LS-61562
 
LW 3170
Lopac0_000720
Lossapina
Lossapina [DCIT]
Loxapin
Loxapina
Loxapina [INN-Spanish]
Loxapine
Loxapine (USAN/INN)
Loxapine [USAN:BAN:INN]
Loxapine [USAN:INN:BAN]
Loxapinsuccinate
Loxapinum
Loxapinum [INN-Latin]
Loxepine
Loxitane
Loxitane IM
MolPort-002-885-838
NCGC00021145-01
NCGC00021145-07
NCGC00022279-03
NCGC00022279-04
NCGC00022279-05
Oxilapine
PDSP1_001058
PDSP2_001042
Prestwick0_000132
Prestwick1_000132
Prestwick2_000132
Prestwick3_000132
QTL1_000050
S 805
S-805
SPBio_001814
SPBio_002143
SUM 3170
SUM-3170
SpecPlus_000823
Spectrum2_001737
Spectrum3_001830
Spectrum5_001857
Spectrum_000355
UNII-LER583670J
Xylac
ZINC19796158
loxapine
oxilapine
42
Tramadolapproved, investigationalPhase 119527203-92-533741
Synonyms:
(+)-(R,R)-trans-Tramadol
(+)-Tramadol
(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol
(+)-trans-Tramadol free ba
(1R,2R)-2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol
(1R,2R)-2-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexanol
(1R,2R)-2-[(dimethylamino)methyl]-1-[3-(methyloxy)phenyl]cyclohexanol
27203-92-5
AC1L1Q6E
AC1Q59O2
AKOS005066335
Amanda
Amanda (TN)
BIDD:GT0075
C07153
CHEMBL1066
CID33741
Conzip
Crispin
D08623
DB00193
Durela
EINECS 248-319-6
HMS2090D10
Jsp005295
LS-57115
LS-57116
 
MLS000333190
MolPort-002-507-778
NCGC00159343-02
Ralivia
Ralivia ER
Ralivia Flashtab
Ralivia flashtab
Ryzolt
SMR000436547
STOCK4S-19075
Tradonal odis
Tramadol
Tramadol (INN)
Tramadol HCl
Tramadol HCl BP/EP
Tramadol Hydrochloride
Tramadol [INN:BAN]
Tramadol hydrochloride
Tramadolum
Tramadolum [INN-Latin]
Tramal
Tramodol Hcl
Tridural
UNII-39J1LGJ30J
Ultram
Ultram ER
Zydol
tramadol
43
QuinidineapprovedPhase 14156-54-2441074
Synonyms:
(+)-quinidine
(-)-Quinine
(8R,9S)-Quinidine
(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol
(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol
11010-73-4
12239-42-8
128544-03-6
130-89-2
130-95-0
1407-83-6
21480-31-9
22600_FLUKA
22620_FLUKA
22620_SIGMA
50-54-4
500225-45-6
549-56-4
55980-20-6
56-54-2
572-59-8
6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol
6119-70-6
6151-39-9
6151-40-2
6183-68-2
6591-63-5
6912-57-8
72646-90-3
767303-40-2
804-63-7
840482-04-4
845886-64-8
857212-53-4
864908-93-0
875538-34-4
882741-47-1
883881-01-4
888714-03-2
890027-24-4
894767-09-0
898813-59-7
898814-00-1
898814-28-3
899813-83-3
900786-66-5
900789-95-9
906550-97-8
909263-47-4
909767-48-2
909882-78-6
910878-25-0
910880-97-6
910899-51-3
911445-75-5
918778-04-8
AB00514657
AC1L199L
AC1L1ANE
AC1L1LHL
AC1L1R7Y
AC1L3RNZ
AC1L9AHT
AC1L9AHW
AC1LCUGN
AC1LDI43
AC1LDI46
AC1MBNAI
AC1MHDEF
AC1MHUCH
AC1MHWS7
AC1MI1Q5
AC1NSV55
AC1NSV58
AC1NSZYR
AC1NSZYU
AC1NUNML
AC1NUNMO
AC1NX8JM
AC1O56R7
AC1O7EE0
AC1O7GNZ
AC1OAH7Z
AC1OCD5W
AC1OCD62
AC1OFCPL
AC1Q4EZ5
AC1Q4EZ6
AC1Q58AF
AR-1A4833
AR-1H2065
Aflukin
Apo-Quinidine
Auriquin
BB_NC-0697
BIB1110
BIDD:GT0144
Biquin Durules
C06526
C06527
C20H24N2O2
CCRIS 5755
CCRIS 672
CHEBI:111177
CHEBI:15854
CHEBI:28593
CHEMBL170
CHEMBL21578
CHEMBL576997
CHEMBL601807
CHEMBL97
CID10448938
CID1065
CID25522
CID2728270
CID3000825
CID3032576
CID3034034
CID3036746
CID441073
CID441074
CID5317111
CID5317112
CID5320867
CID5320868
 
CID5484444
CID5484450
CID5748152
CID5953
CID637552
CID6453100
CID6602154
CID6604605
CID667448
CID667449
CID6857801
CID6916033
CID6916036
CID7048767
CID8549
CID94175
CID9967055
CIN-QUIN
CPD000857275
Cardioquin
Chinidin
Chinidine
Chinidinum
Chinin
Chinine
Cin-Quin
Coccinine
Coco-Quinine
Conchinin
Conchinine
Conquinine
D08458
D08460
DB00468
DB00908
Duraquin
Epiquinidine
FT-0082277
GNF-PF-5459
GNF-Pf-180
GNF-Pf-5423
HMS1304I22
HMS1607A11
HMS1989J09
HMS2089E05
HSDB 225
HSDB 2501
I14-3348
I14-3397
IBS-L0034250
IDI1_000134
KBio1_000134
KBio2_001392
KBio2_003960
KBio2_006528
KBio3_001551
KST-1A1085
Kinidin
Kinidin (TN)
L001278
LS-141252
LS-187236
LS-194958
LS-221
LS-4562
LT00645788
Lopac-Q-0875
Lopac-Q-1250
MLS001304041
MLS001335913
MLS001335914
NCI-C56246
NCI60_004320
NINDS_000134
NSC 192949
NSC 5362
NSC131458
NSC192949
NSC5362
NSC667852
Novoquinidin
OR28880
Pitayin
Pitayine
Q0006
Q3625_SIGMA
Quin-Release
Quinact
Quinaglute
Quinaglute Dura-Tabs
Quinalan
Quinate
Quinatime
Quindan
Quindine
Quinicardine
Quinidex
Quinidex Extentabs
Quinidina
Quinidine
Quinidine Gluconate
Quinidine Sulfate
Quiniduran
Quinimax
Quinine
Quinine Dab
Quinora
Quniacridine
RH01857
SAM002264644
SB01652
SMP1_000254
SMR000718748
SMR000857275
SPBio_001375
SPBio_002379
ST056282
TCMDC-131239
TNP00086
alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol
beta-Quinine
bmse000511
chinidinum
chininum
quinidina
quinidine
quinina
β-quinine
44
VerapamilapprovedPhase 111252-53-92520
Synonyms:
(+-)-Verapamil
(+/-)-VERAPAMIL
(1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile
2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
52-53-9
56949-77-0
AB00053495
AC-16016
AC1L1DV5
Akilen
Anpec
Apo-Verap
Arpamyl
Arpamyl LP
BPBio1_000268
BRD-A09533288-001-02-7
BRD-A09533288-003-05-6
BSPBio_000242
BSPBio_001513
BSPBio_002358
Berkatens
Bio-0754
Bio1_000425
Bio1_000914
Bio1_001403
Bio2_000233
Bio2_000713
C07188
C27H38N2O4
CCRIS 6749
CHEBI:9948
CHEMBL6966
CID2520
CP-16533-1
CP-165331
Calan
Calan SR
Calan Sr
Calan sr
Calaptin
Calaptin 240 SR
Calcan
Cardiabeltin
Cardiagutt
Cardibeltin
Cardioprotect
Caveril
Civicor
Civicor Retard
Coraver
Cordilox
Cordilox SR
Corpamil
Covera-HS
Covera-Hs
Covera-hs
D-365
D02356
DB00661
Dexverapamil
Dignover
Dilacoran
Dilacoran HTA
DivK1c_000399
Drosteakard
Durasoptin
EINECS 200-145-1
EINECS 260-462-6
Elthon
FT-0080127
Falicard
Finoptin
Flamon
Geangin
HMS1791L15
HMS1989L15
HMS2089H17
Harteze
Hexasoptin
Hexasoptin Retard
Hormitol
I06-0063
IDI1_000399
IDI1_033983
Ikacor
Ikapress
Inselon
Iproveratril
Isoptimo
Isoptin
Isoptin Retard
Isoptin SR
Isoptin sr
Isoptine
Isoptino
Isotopin
Izoptin
Jenapamil
KBio1_000399
KBio2_000233
KBio2_002343
KBio2_002801
KBio2_004911
KBio2_005369
KBio2_007479
KBio3_000465
KBio3_000466
KBio3_002823
KBioGR_000233
 
KBioGR_001372
KBioGR_002343
KBioSS_000233
KBioSS_002346
L001330
LS-174
Lekoptin
Lodixal
Lopac0_001237
Magotiron
Manidon
Manidon Retard
MolPort-000-721-258
NCGC00016083-14
NCGC00024710-04
NCGC00024710-05
NCGC00024710-06
NCGC00024710-07
NCGC00024710-08
NCGC00024710-09
NCI60_020143
NINDS_000399
NSC272366
NU-Verap
Novapamyl LP
Novo-Veramil
Nu-Verap
Ormil
Praecicor
Prestwick0_000141
Prestwick1_000141
Prestwick2_000141
Prestwick3_000141
Quasar
Rapam
Robatelan
SID104171262
SID124881789
SID124881790
SPBio_001820
SPBio_002181
STK538085
Securon
Spectrum2_001740
Spectrum4_000906
Spectrum5_001786
Tarka
UNII-CJ0O37KU29
Univer
Univex
VERAPAMIL
Vasolan
Vasomil
Vasopten
Vera-Sanorania
Verabeta
Veracaps SR
Veracim
Veracor
Verahexal
Veraloc
Veramex
Veramil
Verapamil
Verapamil (USAN/INN)
Verapamil AL
Verapamil Acis
Verapamil Atid
Verapamil Basics
Verapamil Ebewe
Verapamil HCl
Verapamil Henning
Verapamil Hydrochloride
Verapamil Injection
Verapamil MSD
Verapamil NM
Verapamil NM Pharma
Verapamil Nordic
Verapamil PB
Verapamil Riker
Verapamil SR
Verapamil Verla
Verapamil [USAN:BAN:INN]
Verapamil [USAN:INN:BAN]
Verapamil [Usan:Ban:Inn]
Verapamil-AbZ
Verapamilo
Verapamilo [INN-Spanish]
Verapamilum
Verapamilum [INN-Latin]
Verapin
Verapress 240 SR
Veraptin
Verasal
Verasifar
Veratensin
Verdilac
Verelan
Verelan PM
Verelan Pm
Verelan SR
Verexamil
Veroptinstada
Verpamil
Vetrimil
Vortac
Vérapamil
alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile
alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
cMAP_000023
delta-365
nchembio.368-comp2
nchembio.79-comp5
45
PhenylephrineapprovedPhase 138559-42-76041
Synonyms:
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-α-(methylaminomethyl)benzyl alcohol
(R)-2-Hydroxy-2-(3-hydroxyphenyl)-N-methylethylamine
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol
1416-03-1
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol
59-42-7
61-76-7 (hydrochloride)
AC1L1LO9
AC1Q40UF
AI3-02402
AK-Dilate
AK-Nefrin
Adrianol
Ah-Chew
Ak-Dilate
Ak-Nefrin
Ak-dilate
Ak-nefrin
Alcon Efrin
Alcon efrin
Alconefrin Nasal Drops 12
Alconefrin Nasal Drops 25
Alconefrin Nasal Drops 50
Alconefrin Nasal Spray 25
BIDD:GT0157
BSPBio_002420
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)- (9CI)
Biomydrin
C07441
CCRIS 8464
CHEBI:8093
CHEMBL1215
CID6041
Cyclomydril
D08365
DB00388
Dilatair
Dimetane
Dionephrine
DivK1c_000597
Doktors
Duration
EINECS 200-424-8
EINECS 215-810-1
Fenilefrina
Fenilefrina [INN-Spanish]
HSDB 3383
Help I Have A Stuffy Nose
I-Phrine
IDI1_000597
Isophrim
Isophrin
Isopto Frin
KBio1_000597
KBio2_001581
KBio2_004149
KBio2_006717
KBio3_001640
KBioGR_001313
KBioSS_001581
L-Phenylephedrine
L-Phenylephrine
LS-43027
Lopac-P-6126
Lopac0_000920
M-Methylaminoethanolphenol
M-Oxedrine
M-Sympathol
M-Sympatol
M-Synephrine
Mesaton
 
Mesatone
Mesatonum
Metaoxedrin
Metaoxedrine
Metaoxedrinum
Metasympatol
Metasynephrine
Metsatonum
Mezaton
Minims Phenylephrine
MolPort-001-792-191
Mydfrin
NCGC00015825-01
NCGC00015825-02
NCGC00024257-03
NCGC00024257-05
NCGC00024257-06
NINDS_000597
Neo-Synephrine
Neo-Synephrine Nasal Drops
Neo-Synephrine Nasal Jelly
Neo-Synephrine Nasal Spray
Neo-Synephrine Pediatric Nasal Drops
Neofrin
Neophryn
Neosynephrine
North Sinus Decongestant
Nostril
Nostril Spray Pump
Nostril Spray Pump Mild
Ocu-Phrin Sterile Eye Drops
Ocu-Phrin Sterile Ophthalmic Solution
Ocugestrin
P0395
PDSP1_001108
PDSP2_001092
Phenoptic
Phenylephrine
Phenylephrine (INN)
Phenylephrine Hydrochloride
Phenylephrine Minims
Phenylephrine Minims (TN)
Phenylephrine [INN:BAN]
Phenylephrine hydrochloride
Phenylephrinum
Phenylephrinum [INN-Latin]
Prefrin
Prefrin Liquifilm
Pyracort D
R(-)-Mezaton
R(-)-Phenylephrine
Relief Eye Drops for Red Eyes
Rhinall
SPBio_001280
Spectrum2_001280
Spectrum3_000770
Spectrum4_000967
Spectrum5_001411
Spectrum_001101
Spersaphrine
Tannins, compds. with (R)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol
UNII-1WS297W6MV
Vicks Sinex
Visadron
l-(3-Hydroxyphenyl)-N-methylethanolamine
l-1-(m-Hydroxyphenyl)-2-methylaminoethanol
l-alpha-Hydroxy-beta-methylamino-3-hydroxy-L-ethylbenzene
l-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol
m-Methylaminoethanolphenol
m-Oxedrine
m-Sympathol
m-Sympatol
m-Synephrine
phenylephrine
46
MexiletineapprovedPhase 11931828-71-44178
Synonyms:
(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine
(+-)-1-(2,6-dimethylphenoxy)propan-2-amine
(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane
1-(2',6'-Dimethylphenoxy)-2-aminopropane
1-(2,6-Dimethylphenoxy)-2-propanamine
1-(2,6-dimethylphenoxy)propan-2-amine
1-Methyl-2-(2,6-xylyloxy)ethanamine
1-Methyl-2-(2,6-xylyloxy)ethylamine
1-methyl-2-(2,6-xylyloxy)ethanamine
2-(2-Aminopropoxy)-1,3-DiMethyl-Benzene Hydrochloride
2-(2-aminopropoxy)-1,3-dimethylbenzene
31828-71-4
5370-01-4 (hydrochloride)
AB00053683
AC1L1HL7
AC1Q2BC5
AC1Q2BC6
BPBio1_000026
BRD-A64092382-003-04-3
BRN 2092205
BSPBio_000022
BSPBio_002254
C07220
CHEBI:115958
CHEBI:6916
CHEMBL558
CID4178
D08215
DB00379
DivK1c_000834
EINECS 250-825-7
I01-6374
IDI1_000834
KBio1_000834
KBio2_002082
KBio2_004650
KBio2_007218
 
KBio3_001474
KBioGR_001270
KBioSS_002082
KO-1173
KO1173
KOE-1173
LS-68257
Lopac0_000784
Mexiletene
Mexiletina
Mexiletina [INN-Spanish]
Mexiletine
Mexiletine (INN)
Mexiletine HCL
Mexiletine Hydrochloride
Mexiletine [INN:BAN]
Mexiletinum
Mexiletinum [INN-Latin]
Mexilitine
Mexilétine
Mexitil
Mexityl
MolPort-001-790-944
NCGC00015659-04
NCGC00162253-01
NCGC00162253-02
NINDS_000834
Prestwick0_000241
Prestwick1_000241
Prestwick2_000241
Prestwick3_000241
SBB070242
SPBio_002241
Spectrum3_000727
Spectrum4_000795
Spectrum5_001279
Spectrum_001602
UNII-1U511HHV4Z
47
SotalolapprovedPhase 1363930-20-95253
Synonyms:
.beta.-Cardone
27948-47-6
3930-20-9
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide
4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid
959-24-0 (mono-hydrochloride)
AB00514715
AC-19021
AC1L1JXU
BPBio1_001069
BRD-A33168282-003-03-2
BSPBio_000971
Betapace
C07309
C12H20N2O3S
CCRIS 4204
CHEMBL471
CID5253
D08525
DB00489
Darob mite
Darob mite (TN)
HMS2089K09
L013427
LS-90249
Lopac0_001055
MJ-1999
 
Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)- (9CI)
MolPort-002-042-381
N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide
N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide
NCGC00015919-05
NCGC00024899-02
NCGC00024899-03
Prestwick0_000966
Prestwick1_000966
Prestwick2_000966
Prestwick3_000966
SBB066409
SPBio_002892
Sorine
Sotalol
Sotalol (INN)
Sotalol HCL
Sotalol Hydrochloride
Sotalol Monohydrochloride
Sotalol [INN:BAN]
Sotalolo
Sotalolum
Sotalolum [INN-Latin]
UNII-A6D97U294I
beta-Cardone
d,l-Sotalol
sotalol
48
DofetilideapprovedPhase 114115256-11-671329
Synonyms:
1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane
1-MSPMPE
115256-11-6
AC-385
AC1L2FYH
AC1Q6VUS
Ambap115256-11-6
C063533
C07751
C19H27N3O5S2
CHEBI:4681
CHEMBL473
CID71329
CPD000466333
D00647
DB00204
Dofetilida
Dofetilida [INN-Spanish]
Dofetilide
Dofetilide (JAN/USAN/INN)
Dofetilide [USAN:BAN:INN]
Dofetilidum
Dofetilidum [INN-Latin]
HMS2051N14
 
HMS2089F03
I06-0340
LS-90151
MLS000759442
MLS001424185
Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl)
MolPort-003-847-012
N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide
N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide
NCGC00164549-01
S1658_Selleck
SAM001246621
SMR000466333
TL8000450
Tikosyn
Tikosyn (TN)
Tikosyn, UK68798, Dofetilide
UK 68,798
UK 68798
UK-68,798
UK-68798
UNII-R4Z9X1N2ND
Xelide
beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide
beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide
49
DiltiazemapprovedPhase 16842399-41-739186
Synonyms:
(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester
(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester
(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
(2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate
(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
(2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one
144604-00-2
33286-22-5
42399-41-7
AC-936
AC1L2181
AC1Q6LHX
Acalix
Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester
Adizem
Aldizem
Altiazem
Anginyl
Angizem
Anoheal
Apo-Diltiaz
BIDD:GT0548
BPBio1_000230
BRD-K24023109-001-02-5
BRD-K24023109-003-03-9
BRN 3573079
BSPBio_000208
BSPBio_001311
Bio1_000371
Bio1_000860
Bio1_001349
Britiazim
Bruzem
C06958
C22H26N2O4S
CHEBI:101278
CHEMBL23
CID39186
Calcicard
Cardil
Cardizem
Cardizem (Hydrochloride)
Cardizem CD
Cardizem SR
Cardizen LA
Cartia XT
Citizem
Cormax
D-cis-Diltiazem
D07845
DB00343
Deltazen
Dilacor
Dilacor-XR
Diladel
Dilcontin
Dilpral
 
Dilren
Dilrene
Dilt-cd
Dilta-Hexal
Diltia
Diltiazem
Diltiazem (INN)
Diltiazem Hydrochloride
Diltiazem [INN:BAN]
Diltiazem hydrochloride
Diltiazemum
Diltiazemum [INN-Latin]
Dilticard
Diltzac
Dilzem
Dilzen
EINECS 255-796-4
Endrydil
FT-0081415
HMS1791B13
HMS1989B13
HMS2089H09
HSDB 6528
Herbesser
Incoril AP
LS-40510
Lopac0_000327
MK-793 (Malate)
Masdil
MolPort-002-509-369
NCGC00024309-02
NCGC00024309-04
NCGC00024309-05
NCGC00024309-06
NCGC00024309-07
NCGC00024309-08
NCGC00024309-09
NCGC00024309-10
Novo-Diltazem
Nu-Diltiaz
Prestwick0_000134
Prestwick1_000134
Prestwick2_000134
Prestwick3_000134
RG 83606 (Hydrochloride)
SPBio_002147
STOCK1N-03672
Surazem (TN)
Syn-Diltiazem
Tiamate
Tiazac
Tiazac Tildiem
Tiazac XC
Tocris-0685
UNII-EE92BBP03H
Viazem
[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate
d-cis-Diltiazem
diltiazem
nchembio.368-comp1
50
LidocaineapprovedPhase 1991137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Afterburn
Akten
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bikini Zone Medicated
Bikini Zone Medicated Creme
Bio-0767
Bio-scriptives Lidum
Bio-scriptives Lidum Hemorroidal (anorectal)
Bio-scriptives Lidum Topical Analgesic
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
Burn Relief Leader
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Comfortcaine
Cuivasil
Curacaine Transdermal Corporation
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
Derma Numb
DermaFlex
Desert Harvest Releveum
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Dr. Numb
Dr. Richs Numbing
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gigi Anesthetic Numbing
Gravocain
H-releve Hemorrhoidal
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
Hawaiian Tropic
Hush Anesthetic
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
LS-805
Lanabiotic
 
Laryng-o-jet
Leostesin
Lida-Mantle
Lidall
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine 4% Cream
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Hydrochloride
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocaine hydrochloride
Lidocainum
Lidocainum [INN-Latin]
Lidocare Mist
Lidocaton
Lidocream 4
Lidocream 5
Lidoderm
Lidoderm 5
Lidoject-1
Lidoject-2
Lifestyles Epic Male Genital Desensitizer
Lignocaine
Lignocainum
Lingocaine
Lmx4
Lmx5
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Numb Master Topical Anesthetic
Numb Nuts
Ocean Potion Instant Burn Relief Ice
Octocaine
Octocaine-100
Octocaine-50
Plum Smooth Plumb Numb Gelee
Premjact Male Desensitizer Pound International
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Recticare
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Simplicity Desensitizing
Simply Numb Endure
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Sole Serum
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Walgreens Aloe Vera Pain Relieving
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocaine-mpf
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zcaine Fast Acting Anesthetic
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide

Interventional clinical trials:

(show top 50)    (show all 79)
idNameStatusNCT IDPhase
1A Study of Aripiprazole (Abilify) in Patients With Bipolar ManiaCompletedNCT00261443Phase 4
2Genetics of QT Response to MoxifloxacinEnrolling by invitationNCT01936480Phase 4
3Imaging of Brain Amyloid Plaques in the Aging PopulationEnrolling by invitationNCT00950430Phase 4
4Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care UnitEnrolling by invitationNCT02025855Phase 4
5Pediatric Lead Extractability and Survival Evaluation (PLEASE)TerminatedNCT00335036Phase 4
6Pharmacokinetics and Safety of MoxifloxacinTerminatedNCT01329250Phase 4
7Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3RecruitingNCT02300558Phase 3
8Registry of Unexplained Cardiac ArrestRecruitingNCT00292032Phase 3
9Cardiac Sympathetic Denervation Surgery for Prevention of Ventricular TacharrhythmiasNot yet recruitingNCT01013714Phase 3
10Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)Not yet recruitingNCT02589782Phase 2, Phase 3
11Influence of Progesterone Administration on Drug-Induced QT Interval LengtheningCompletedNCT01929083Phase 2
12Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body DiseaseCompletedNCT00947960Phase 2
13A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic PatientsCompletedNCT00845026Phase 2
14Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With RanolazineRecruitingNCT01728025Phase 2
15Efficacy Study of Sodium Channel Blocker in LQT3 PatientsRecruitingNCT01648205Phase 2
16Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of GastroparesisTerminatedNCT01323582Phase 2
17Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy AdultsCompletedNCT02365532Phase 1
18Study of the Effect of GS-6615 in Subjects With LQT-3CompletedNCT01849003Phase 1
19Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal FunctionCompletedNCT02441829Phase 1
20Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy SubjectsCompletedNCT00316459Phase 1
21Genetic Sources of Variability of the Adaptation of the Ventricular RepolarisationCompletedNCT00773201Phase 1
22Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy VolunteersCompletedNCT00199225Phase 1
23Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current BlockCompletedNCT02308748Phase 1
24To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult SubjectsCompletedNCT01449188Phase 1
25A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy VolunteersCompletedNCT01947920Phase 1
26Food and Insulin Effect on QT/QTC Interval of ECGCompletedNCT01642485Phase 1
27Selections of Subjects With Important Changes in Their Cardiac Repolarization Parameters for the Procurement of Skin and Blood SamplesCompletedNCT01338441Phase 1
28Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy SubjectsCompletedNCT01140425Phase 1
29QT/QTc Study of 2 Doses of ADASUVE®CompletedNCT01854710Phase 1
30A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult SubjectsCompletedNCT00789568Phase 1
31Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran EtexilateCompletedNCT02171624Phase 1
32Effect of GS-6615 on QT, Safety, and Tolerability in Adults With Long QT2 SyndromeRecruitingNCT02365506Phase 1
33Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian VolunteersRecruitingNCT02119091Phase 1
34Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic FunctionRecruitingNCT02412098Phase 1
35A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorRecruitingNCT02365662Phase 1
36Methadone Pharmacokinetics and Cardiac Effects in NewbornsActive, not recruitingNCT00715988Phase 1
37Effect of Potassium and Acetazolamide on People With Andersen-Tawil SyndromeTerminatedNCT00839501Phase 1
38The Long QT Syndrome in PregnancyCompletedNCT00488254
39Long QT Syndrome-Population Genetics and Cardiac StudiesCompletedNCT00005176
40ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization PatientsCompletedNCT00399412
41Linkage Study of Long QT Syndrome In An Amish KindredCompletedNCT00005250
42QT-prolongation in Psychiatric HospitalsCompletedNCT02043925
43Drug Interactions With Risk of QT-prolongation in a General HospitalCompletedNCT02043912
44Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University HospitalCompletedNCT02068170
45Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?CompletedNCT01553734
46Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal SubjectsCompletedNCT00588965
47Epidemiology of Long QTand Asian Sudden Death in SleepCompletedNCT00005367
48The Effect of General Anesthesia on the Risk for ArrhythmiaCompletedNCT01174251
49Effects Rapid Atrial Pacing Has on the Electrocardiogram (ECG) in Patients With Dual Chamber PacemakersCompletedNCT00883610
50Ondansetron and the QT Interval In Adult Emergency Department PatientsCompletedNCT01759420

Search NIH Clinical Center for Long Qt Syndrome


Cochrane evidence based reviews: Long QT Syndrome

Genetic Tests for Long Qt Syndrome

About this section

Genetic tests related to Long Qt Syndrome:

id Genetic test Affiliating Genes
1 Long Qt Syndrome22 24

Anatomical Context for Long Qt Syndrome

About this section

MalaCards organs/tissues related to Long Qt Syndrome:

33
Heart, Testes, Brain, Eye

Animal Models for Long Qt Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Long Qt Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.4CACNA1C, CAV3, KCNH2, KCNJ2, KCNQ1, RYR2
2MP:00053769.0AKAP9, ANK2, CACNA1C, CAV3, KCNE1, KCNE2
3MP:00053858.9ANK2, CACNA1C, CAV3, KCND3, KCNE1, KCNH2

Publications for Long Qt Syndrome

About this section

Articles related to Long Qt Syndrome:

(show top 50)    (show all 903)
idTitleAuthorsYear
1
Analysis for Genetic Modifiers of Disease Severity in Patients with Long QT Syndrome Type 2. (25737393)
2015
2
"QT clock" to improve detection of QT prolongation in long QT syndrome patients. (26334569)
2015
3
Combined gating and trafficking defect in Kv11.1 manifests as a malignant long QT syndrome phenotype in a large Danish p.F29L founder family. (26403377)
2015
4
Sudden Cardiac Arrest During Sex in Patients with Either Catecholaminergic Polymorphic Ventricular Tachycardia or Long-QT Syndrome: A Rare But Shocking Experience. (25514987)
2015
5
The Use by Medical Examiners of Genetic Testing for Long QT Syndrome in Suspected Sudden Cardiac Death. (25357104)
2014
6
Clinical Profile of Pediatric Patients with Long QT Syndrome Masquerading as Seizures. (24408398)
2014
7
Risk factors for symptoms in long QT syndrome patients in a single pediatric center. (23566084)
2013
8
Duloxetine-induced life-threatening long QT syndrome. (23440523)
2013
9
QRS fragmentation in acquired long QT syndrome does not always predict torsades of pointes tachycardia: a case report. (23949550)
2013
10
Congenital long QT syndrome with compound mutations in the KCNH2 gene. (24057343)
2013
11
An adolescent with possible arrhythmogenic right ventricular dysplasia and long QT syndrome: evaluation and management. (23347029)
2013
12
Stress proneness in molecularly defined long QT syndrome: a study using temperament assessment by behavioural inhibition system scale. (22936642)
2013
13
Clinical utility gene card for: long-QT syndrome (types 1-13). (23511927)
2013
14
A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome. (23010577)
2013
15
Silent mutation in long QT syndrome: pathogenicity prediction by computer simulation. (22001705)
2012
16
Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. (22199116)
2012
17
Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to I^-blocker therapy in type 1 long-QT syndrome. (22456477)
2012
18
Do infants die of sudden infant death syndrome (SIDS) with long QT syndrome (LQTS) or from LQTS? (22868671)
2012
19
A KCNE1 missense variant (V47I) causing exercise-induced long QT syndrome (Romano Ward). (21907427)
2012
20
Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome. (22786471)
2012
21
Sex hormones and cardiac arrest in long QT syndrome: does progesterone represent a potential new antiarrhythmic therapy? (22381742)
2012
22
Three generations of hereditary long-QT syndrome with complete penetrance caused by the p.G316E KCNQ1 mutation. (20981542)
2011
23
Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome. (21691919)
2011
24
Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2. (21632495)
2011
25
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. (21367833)
2011
26
Vasovagal syncope as a cause of syncope in long-QT syndrome. (21718921)
2011
27
Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report. (21919379)
2011
28
A rare association of long QT syndrome and syndactyly: Timothy syndrome (LQT 8). (21915623)
2011
29
Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. (20339117)
2010
30
Trigger-specific risk factors and response to therapy in long QT syndrome type 2. (20850565)
2010
31
The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. (19926015)
2009
32
A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation. (18929331)
2008
33
SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. (17592081)
2007
34
Mutation of an A-kinase-anchoring protein causes long-QT syndrome. (18093912)
2007
35
Letter by O'Rourke regarding articles, "Prevalence of long-QT syndrome gene variants in sudden infant death syndrome," "Cardiac sodium channel dysfunction in sudden infant death syndrome," and "Contribution of long-QT syndrome genes to sudden infant death syndrome: is it time to consider newborn electrocardiographic screening?". (17646591)
2007
36
Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique. (16254012)
2006
37
Long QT syndrome and short QT syndrome: how to make correct diagnosis and what about eligibility for sports activity. (16645398)
2006
38
Effect of physical training on ventricular repolarization in type 1 long QT syndrome: a pilot study in asymptomatic carriers of the G589D KCNQ1 mutation. (16882680)
2006
39
Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood. (16022964)
2005
40
Neonatal forms of congenital long QT syndrome]. (15214551)
2004
41
Mutant MiRP1 subunits modulate HERG K+ channel gating: a mechanism for pro-arrhythmia in long QT syndrome type 6. (12923204)
2003
42
Electrical alternans in long QT syndrome resembling a Brugada syndrome pattern. (14516346)
2003
43
A novel mutation in KVLQT1 is the molecular basis of inherited long QT syndrome in a near-drowning patient's family. (9702906)
1998
44
Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome. (9834138)
1998
45
Genetics, molecular mechanisms and management of long QT syndrome. (9556090)
1998
46
The long QT syndrome: a novel missense mutation in the S6 region of the KVLQT1 gene. (9272155)
1997
47
Molecular biology of the long QT syndrome: impact on management. (9272507)
1997
48
Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. (9323054)
1997
49
Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. (8790040)
1996
50
A new form of long QT syndrome associated with syndactyly. (7798527)
1995

Variations for Long Qt Syndrome

About this section

Clinvar genetic disease variations for Long Qt Syndrome:

5 (show all 267)
id Gene Variation Type Significance SNP ID Assembly Location
1RYR2NM_001035.2(RYR2): c.1298T> C (p.Leu433Pro)single nucleotide variantPathogenicrs121918602GRCh37Chr 1, 237617696: 237617696
2KCNE1NM_000219.5(KCNE1): c.20C> T (p.Thr7Ile)single nucleotide variantPathogenicrs28933384GRCh37Chr 21, 35821913: 35821913
3KCNE1NM_000219.5(KCNE1): c.226G> A (p.Asp76Asn)single nucleotide variantLikely pathogenic, Pathogenicrs74315445GRCh37Chr 21, 35821707: 35821707
4KCNE1NM_000219.5(KCNE1): c.221C> T (p.Ser74Leu)single nucleotide variantPathogenicrs74315446GRCh37Chr 21, 35821712: 35821712
5KCNH2NM_000238.3(KCNH2): c.1682C> T (p.Ala561Val)single nucleotide variantPathogenicrs121912504GRCh37Chr 7, 150648799: 150648799
6KCNH2NM_000238.3(KCNH2): c.1408A> G (p.Asn470Asp)single nucleotide variantPathogenicrs121912505GRCh37Chr 7, 150649662: 150649662
7KCNH2NM_000238.3(KCNH2): c.1778T> G (p.Ile593Arg)single nucleotide variantPathogenicrs28928904GRCh37Chr 7, 150648703: 150648703
8KCNH2NM_000238.3(KCNH2): c.2464G> A (p.Val822Met)single nucleotide variantPathogenicrs121912506GRCh37Chr 7, 150646072: 150646072
9KCNH2NM_000238.3(KCNH2): c.1882G> A (p.Gly628Ser)single nucleotide variantPathogenicrs121912507GRCh37Chr 7, 150648599: 150648599
10KCNH2NM_000238.3(KCNH2): c.1744C> T (p.Arg582Cys)single nucleotide variantPathogenicrs121912508GRCh37Chr 7, 150648737: 150648737
11KCNH2NM_000238.3(KCNH2): c.1714G> C (p.Gly572Arg)single nucleotide variantPathogenicrs9333649GRCh37Chr 7, 150648767: 150648767
12KCNH2NM_000238.3(KCNH2): c.1468G> A (p.Ala490Thr)single nucleotide variantPathogenicrs28928905GRCh37Chr 7, 150649602: 150649602
13KCNH2NM_000238.3(KCNH2): c.2453C> T (p.Ser818Leu)single nucleotide variantPathogenicrs121912510GRCh37Chr 7, 150646083: 150646083
14KCNH2NM_000238.3(KCNH2): c.2350C> T (p.Arg784Trp)single nucleotide variantPathogenic, risk factorrs12720441GRCh37Chr 7, 150647304: 150647304
15KCNH2NM_000238.3(KCNH2): c.193A> C (p.Thr65Pro)single nucleotide variantPathogenicrs121912511GRCh37Chr 7, 150671913: 150671913
16KCNH2NM_000238.3(KCNH2): c.2255G> A (p.Arg752Gln)single nucleotide variantLikely pathogenic, Pathogenicrs121912512GRCh37Chr 7, 150647399: 150647399
17KCNH2NM_000238.3(KCNH2): c.2582A> T (p.Asn861Ile)single nucleotide variantPathogenicrs121912513GRCh37Chr 7, 150645954: 150645954
18KCNH2NM_000238.3(KCNH2): c.298C> G (p.Arg100Gly)single nucleotide variantPathogenicrs121912515GRCh37Chr 7, 150671808: 150671808
19KCNH2NM_000238.3(KCNH2): c.2738C> T (p.Ala913Val)single nucleotide variantPathogenicrs77331749GRCh37Chr 7, 150644921: 150644921
20KCNH2NM_000238.3(KCNH2): c.1672G> C (p.Ala558Pro)single nucleotide variantPathogenicrs121912516GRCh37Chr 7, 150648809: 150648809
21DSPNM_004415.2(DSP): c.273+5G> Asingle nucleotide variantPathogenicrs200473206GRCh37Chr 6, 7556058: 7556058
22DSPNM_004415.2(DSP): c.3799C> T (p.Arg1267Ter)single nucleotide variantLikely pathogenic, Pathogenicrs121912997GRCh37Chr 6, 7580222: 7580222
23CACNA1CNM_000719.6(CACNA1C): c.1216G> A (p.Gly406Arg)single nucleotide variantPathogenicrs79891110GRCh37Chr 12, 2614110: 2614110
24CACNA1CNM_000719.6(CACNA1C): c.1204G> A (p.Gly402Ser)single nucleotide variantPathogenicrs80315385GRCh37Chr 12, 2614098: 2614098
25ANK2NM_001148.4(ANK2): c.4373A> G (p.Glu1458Gly)single nucleotide variantLikely pathogenic, Pathogenicrs72544141GRCh37Chr 4, 114269433: 114269433
26KCNH2NM_000238.3(KCNH2): c.2900dupC (p.Pro968Alafs)duplicationPathogenicrs786204101GRCh37Chr 7, 150644759: 150644759
27SNTA1NM_003098.2(SNTA1): c.770C> G (p.Ala257Gly)single nucleotide variantPathogenicrs56157422GRCh38Chr 20, 33412714: 33412714
28KCNH2NM_000238.3(KCNH2): c.1128G> A (p.Gln376=)single nucleotide variantPathogenicrs770047651GRCh37Chr 7, 150654379: 150654379
29KCNH2NM_000238.3(KCNH2): c.1841C> T (p.Ala614Val)single nucleotide variantPathogenicrs199472944GRCh37Chr 7, 150648640: 150648640
30KCNH2NM_000238.3(KCNH2): c.1831T> C (p.Tyr611His)single nucleotide variantPathogenicrs199472942GRCh37Chr 7, 150648650: 150648650
31KCNJ2NM_000891.2(KCNJ2): c.913A> C (p.Thr305Pro)single nucleotide variantPathogenicrs199473387GRCh37Chr 17, 68172093: 68172093
32KCNQ1NM_000218.2(KCNQ1): c.532G> C (p.Ala178Pro)single nucleotide variantPathogenicrs120074177GRCh37Chr 11, 2591912: 2591912
33KCNQ1NM_000218.2(KCNQ1): c.565G> A (p.Gly189Arg)single nucleotide variantPathogenicrs104894252GRCh37Chr 11, 2591945: 2591945
34KCNQ1NM_000218.2(KCNQ1): c.916G> A (p.Gly306Arg)single nucleotide variantPathogenicrs120074181GRCh37Chr 11, 2594211: 2594211
35KCNQ1NM_000218.2(KCNQ1): c.935C> T (p.Thr312Ile)single nucleotide variantPathogenicrs120074182GRCh37Chr 11, 2604678: 2604678
36KCNQ1NM_000218.2(KCNQ1): c.569G> A (p.Arg190Gln)single nucleotide variantPathogenicrs120074178GRCh37Chr 11, 2591949: 2591949
37KCNQ1NM_000218.2(KCNQ1): c.760G> A (p.Val254Met)single nucleotide variantLikely pathogenic, Pathogenicrs120074179GRCh37Chr 11, 2593319: 2593319
38KCNQ1NM_000218.2(KCNQ1): c.817C> T (p.Leu273Phe)single nucleotide variantPathogenicrs120074180GRCh37Chr 11, 2594112: 2594112
39KCNQ1NM_000218.2(KCNQ1): c.1022C> A (p.Ala341Glu)single nucleotide variantPathogenicrs12720459GRCh37Chr 11, 2604765: 2604765
40KCNQ1NM_000218.2(KCNQ1): c.1022C> T (p.Ala341Val)single nucleotide variantPathogenicrs12720459GRCh37Chr 11, 2604765: 2604765
41KCNQ1NM_000218.2(KCNQ1): c.1034G> A (p.Gly345Glu)single nucleotide variantPathogenicrs120074183GRCh37Chr 11, 2606443: 2606443
42KCNQ1NM_000218.2(KCNQ1): c.940G> A (p.Gly314Ser)single nucleotide variantPathogenicrs120074184GRCh37Chr 11, 2604683: 2604683
43KCNQ1NM_000218.2(KCNQ1): c.1663C> T (p.Arg555Cys)single nucleotide variantPathogenicrs120074185GRCh37Chr 11, 2797262: 2797262
44KCNQ1NM_000218.2(KCNQ1): c.914G> C (p.Trp305Ser)single nucleotide variantPathogenicrs120074186GRCh37Chr 11, 2594209: 2594209
45KCNQ1NM_000218.2(KCNQ1): c.1552C> T (p.Arg518Ter)single nucleotide variantPathogenicrs17215500GRCh37Chr 11, 2790111: 2790111
46KCNQ1NM_000218.2(KCNQ1): c.1573G> A (p.Ala525Thr)single nucleotide variantPathogenicrs120074188GRCh37Chr 11, 2790132: 2790132
47KCNQ1NM_000218.2(KCNQ1): c.1032G> A (p.Ala344=)single nucleotide variantPathogenicrs1800171GRCh37Chr 11, 2604775: 2604775
48KCNQ1NM_000218.2(KCNQ1): c.1760C> T (p.Thr587Met)single nucleotide variantPathogenicrs120074189GRCh37Chr 11, 2799233: 2799233
49KCNQ1NM_000218.2(KCNQ1): c.1766G> A (p.Gly589Asp)single nucleotide variantPathogenicrs120074190GRCh37Chr 11, 2799239: 2799239
50KCNQ1NM_000218.2(KCNQ1): c.350C> T (p.Pro117Leu)single nucleotide variantPathogenicrs120074191GRCh37Chr 11, 2466678: 2466678
51KCNQ1NM_000218.2(KCNQ1): c.1747C> T (p.Arg583Cys)single nucleotide variantPathogenic, risk factorrs17221854GRCh37Chr 11, 2799220: 2799220
52KCNQ1NM_000218.2(KCNQ1): c.805G> A (p.Gly269Ser)single nucleotide variantPathogenicrs120074193GRCh37Chr 11, 2594100: 2594100
53KCNQ1NM_000218.2(KCNQ1): c.806G> A (p.Gly269Asp)single nucleotide variantPathogenicrs120074194GRCh37Chr 11, 2594101: 2594101
54KCNQ1NM_000218.2(KCNQ1): c.760G> A (p.Val254Met)single nucleotide variantLikely pathogenic, Pathogenicrs120074179GRCh37Chr 11, 2593319: 2593319
55KCNQ1NM_000218.2(KCNQ1): c.613G> A (p.Val205Met)single nucleotide variantPathogenicrs151344631GRCh37Chr 11, 2592563: 2592563
56SCN5ANM_198056.2(SCN5A): c.665G> A (p.Arg222Gln)single nucleotide variantLikely pathogenic, Pathogenicrs45546039GRCh37Chr 3, 38655272: 38655272
57SCN5ANM_000335.4(SCN5A): c.2314G> A (p.Asp772Asn)single nucleotide variantPathogenicrs199473157GRCh37Chr 3, 38629013: 38629013
58KCNQ1NM_000218.2(KCNQ1): c.1016T> C (p.Phe339Ser)single nucleotide variantPathogenicrs199472759GRCh37Chr 11, 2604759: 2604759
59KCNQ1NM_000218.2(KCNQ1): c.1024C> T (p.Leu342Phe)single nucleotide variantPathogenicrs199472760GRCh37Chr 11, 2604767: 2604767
60KCNQ1NM_000218.2(KCNQ1): c.1031C> T (p.Ala344Val)single nucleotide variantPathogenicrs199472763GRCh37Chr 11, 2604774: 2604774
61KCNQ1NM_000218.2(KCNQ1): c.1032+1G> Asingle nucleotide variantLikely pathogenic, Pathogenicrs397508070GRCh37Chr 11, 2604776: 2604776
62KCNQ1NM_000218.2(KCNQ1): c.1046C> G (p.Ser349Trp)single nucleotide variantPathogenicrs199472765GRCh37Chr 11, 2606455: 2606455
63KCNQ1NM_000218.2(KCNQ1): c.1058T> C (p.Leu353Pro)single nucleotide variantPathogenicrs199473403GRCh37Chr 11, 2606467: 2606467
64KCNQ1NM_000218.2(KCNQ1): c.1070A> G (p.Gln357Arg)single nucleotide variantPathogenicrs199473405GRCh37Chr 11, 2606479: 2606479
65KCNQ1NM_000218.2(KCNQ1): c.1085A> G (p.Lys362Arg)single nucleotide variantPathogenicrs12720458GRCh37Chr 11, 2606494: 2606494
66KCNQ1NM_000218.2(KCNQ1): c.1087C> A (p.His363Asn)single nucleotide variantPathogenicrs199473408GRCh37Chr 11, 2606496: 2606496
67KCNQ1NM_000218.2(KCNQ1): c.1096C> T (p.Arg366Trp)single nucleotide variantLikely pathogenic, Pathogenicrs199473411GRCh37Chr 11, 2606505: 2606505
68KCNQ1NM_000218.2(KCNQ1): c.1121T> A (p.Leu374His)single nucleotide variantPathogenicrs199472767GRCh37Chr 11, 2606530: 2606530
69KCNQ1NM_000218.2(KCNQ1): c.1189C> T (p.Arg397Trp)single nucleotide variantLikely pathogenic, Pathogenicrs199472776GRCh37Chr 11, 2608860: 2608860
70KCNQ1NM_000218.2(KCNQ1): c.1354C> T (p.Arg452Trp)single nucleotide variantLikely pathogenic, Pathogenicrs140452381GRCh37Chr 11, 2610045: 2610045
71KCNQ1NM_000218.2(KCNQ1): c.136G> A (p.Ala46Thr)single nucleotide variantPathogenicrs199473671GRCh37Chr 11, 2466464: 2466464
72KCNQ1NM_000218.2(KCNQ1): c.1553G> C (p.Arg518Pro)single nucleotide variantPathogenicrs145974930GRCh37Chr 11, 2790112: 2790112
73KCNQ1NM_000218.2(KCNQ1): c.1559T> G (p.Met520Arg)single nucleotide variantPathogenicrs199473479GRCh37Chr 11, 2790118: 2790118
74KCNQ1NM_000218.2(KCNQ1): c.1571T> G (p.Val524Gly)single nucleotide variantPathogenicrs199472790GRCh37Chr 11, 2790130: 2790130
75KCNQ1NM_000218.2(KCNQ1): c.1576A> G (p.Lys526Glu)single nucleotide variantPathogenicrs199472792GRCh37Chr 11, 2790135: 2790135
76KCNQ1NM_000218.2(KCNQ1): c.1588C> T (p.Gln530Ter)single nucleotide variantPathogenicrs397508097GRCh37Chr 11, 2790147: 2790147
77KCNQ1NM_000218.2(KCNQ1): c.1615C> T (p.Arg539Trp)single nucleotide variantPathogenicrs199472795GRCh37Chr 11, 2797214: 2797214
78KCNQ1NM_000218.2(KCNQ1): c.1637C> T (p.Ser546Leu)single nucleotide variantPathogenicrs199473480GRCh37Chr 11, 2797236: 2797236
79KCNQ1NM_000218.2(KCNQ1): c.1664G> A (p.Arg555His)single nucleotide variantPathogenicrs199472800GRCh37Chr 11, 2797263: 2797263
80KCNQ1NM_000218.2(KCNQ1): c.1697C> A (p.Ser566Tyr)single nucleotide variantPathogenicrs199472804GRCh37Chr 11, 2798227: 2798227
81KCNQ1NM_000218.2(KCNQ1): c.1697C> T (p.Ser566Phe)single nucleotide variantLikely pathogenic, Pathogenicrs199472804GRCh37Chr 11, 2798227: 2798227
82KCNQ1NM_000218.2(KCNQ1): c.1700T> C (p.Ile567Thr)single nucleotide variantPathogenicrs199472805GRCh37Chr 11, 2798230: 2798230
83KCNQ1NM_000218.2(KCNQ1): c.1702G> A (p.Gly568Arg)single nucleotide variantPathogenicrs199472807GRCh37Chr 11, 2798232: 2798232
84KCNQ1NM_000218.2(KCNQ1): c.1768G> A (p.Ala590Thr)single nucleotide variantPathogenicrs199472813GRCh37Chr 11, 2799241: 2799241
85KCNQ1NM_000218.2(KCNQ1): c.1772G> A (p.Arg591His)single nucleotide variantPathogenicrs199472814GRCh37Chr 11, 2799245: 2799245
86KCNQ1NM_000218.2(KCNQ1): c.1781G> A (p.Arg594Gln)single nucleotide variantPathogenicrs199472815GRCh37Chr 11, 2799254: 2799254
87KCNQ1NM_000218.2(KCNQ1): c.1781G> C (p.Arg594Pro)single nucleotide variantPathogenicrs199472815GRCh37Chr 11, 2799254: 2799254
88NM_000218.2(KCNQ1): c.1876G> A (p.Gly626Ser)single nucleotide variantPathogenicrs199472821GRCh37Chr 11, 2869078: 2869078
89KCNQ1NM_000218.2(KCNQ1): c.19C> T (p.Pro7Ser)single nucleotide variantPathogenicrs199473443GRCh37Chr 11, 2466347: 2466347
90KCNQ1NM_000218.2(KCNQ1): c.217C> A (p.Pro73Thr)single nucleotide variantPathogenicrs199472676GRCh37Chr 11, 2466545: 2466545
91KCNQ1NM_000218.2(KCNQ1): c.332A> G (p.Tyr111Cys)single nucleotide variantPathogenicrs199472678GRCh37Chr 11, 2466660: 2466660
92KCNQ1NM_000218.2(KCNQ1): c.365G> A (p.Cys122Tyr)single nucleotide variantPathogenicrs199472681GRCh37Chr 11, 2466693: 2466693
93KCNQ1NM_000218.2(KCNQ1): c.409C> T (p.Leu137Phe)single nucleotide variantPathogenicrs199473450GRCh37Chr 11, 2549180: 2549180
94KCNQ1NM_000218.2(KCNQ1): c.502G> A (p.Gly168Arg)single nucleotide variantPathogenicrs179489GRCh37Chr 11, 2591882: 2591882
95KCNQ1NM_000218.2(KCNQ1): c.502G> C (p.Gly168Arg)single nucleotide variantPathogenicrs179489GRCh37Chr 11, 2591882: 2591882
96KCNQ1NM_000218.2(KCNQ1): c.520C> T (p.Arg174Cys)single nucleotide variantPathogenicrs199472696GRCh37Chr 11, 2591900: 2591900
97KCNQ1NM_000218.2(KCNQ1): c.521G> A (p.Arg174His)single nucleotide variantPathogenicrs199472697GRCh37Chr 11, 2591901: 2591901
98KCNQ1NM_000218.2(KCNQ1): c.532G> A (p.Ala178Thr)single nucleotide variantPathogenicrs120074177GRCh37Chr 11, 2591912: 2591912
99KCNQ1NM_000218.2(KCNQ1): c.535G> A (p.Gly179Ser)single nucleotide variantPathogenicrs199473394GRCh37Chr 11, 2591915: 2591915
100KCNQ1NM_000218.2(KCNQ1): c.560T> C (p.Leu187Pro)single nucleotide variantPathogenicrs199473399GRCh37Chr 11, 2591940: 2591940
101KCNQ1NM_000218.2(KCNQ1): c.568C> T (p.Arg190Trp)single nucleotide variantPathogenicrs199473662GRCh37Chr 11, 2591948: 2591948
102KCNQ1NM_000218.2(KCNQ1): c.604G> A (p.Asp202Asn)single nucleotide variantPathogenicrs199472702GRCh37Chr 11, 2591984: 2591984
103KCNQ1NM_000218.2(KCNQ1): c.674C> T (p.Ser225Leu)single nucleotide variantPathogenicrs199473456GRCh37Chr 11, 2592624: 2592624
104KCNQ1NM_000218.2(KCNQ1): c.686G> A (p.Gly229Asp)single nucleotide variantPathogenicrs199472708GRCh37Chr 11, 2593245: 2593245
105KCNQ1NM_000218.2(KCNQ1): c.691C> T (p.Arg231Cys)single nucleotide variantPathogenicrs199473457GRCh37Chr 11, 2593250: 2593250
106KCNQ1NM_000218.2(KCNQ1): c.692G> A (p.Arg231His)single nucleotide variantPathogenicrs199472709GRCh37Chr 11, 2593251: 2593251
107KCNQ1NM_000218.2(KCNQ1): c.724G> A (p.Asp242Asn)single nucleotide variantPathogenicrs199472712GRCh37Chr 11, 2593283: 2593283
108KCNQ1NM_000218.2(KCNQ1): c.728G> A (p.Arg243His)single nucleotide variantPathogenicrs120074196GRCh37Chr 11, 2593287: 2593287
109KCNQ1NM_000218.2(KCNQ1): c.752T> C (p.Leu251Pro)single nucleotide variantPathogenicrs199472716GRCh37Chr 11, 2593311: 2593311
110KCNQ1NM_000218.2(KCNQ1): c.760G> T (p.Val254Leu)single nucleotide variantPathogenicrs120074179GRCh37Chr 11, 2593319: 2593319
111KCNQ1NM_000218.2(KCNQ1): c.773A> G (p.His258Arg)single nucleotide variantPathogenicrs199472718GRCh37Chr 11, 2593332: 2593332
112KCNQ1NM_000218.2(KCNQ1): c.775C> T (p.Arg259Cys)single nucleotide variantPathogenicrs199472719GRCh37Chr 11, 2593334: 2593334
113KCNQ1NM_000218.2(KCNQ1): c.776G> A (p.Arg259His)single nucleotide variantPathogenicrs199472720GRCh37Chr 11, 2593335: 2593335
114KCNQ1NM_000218.2(KCNQ1): c.776G> T (p.Arg259Leu)single nucleotide variantPathogenicrs199472720GRCh37Chr 11, 2593335: 2593335
115KCNQ1NM_000218.2(KCNQ1): c.794C> T (p.Thr265Ile)single nucleotide variantPathogenicrs199472724GRCh37Chr 11, 2594089: 2594089
116KCNQ1NM_000218.2(KCNQ1): c.797T> C (p.Leu266Pro)single nucleotide variantPathogenicrs199473460GRCh37Chr 11, 2594092: 2594092
117KCNQ1NM_000218.2(KCNQ1): c.830C> G (p.Ser277Trp)single nucleotide variantPathogenicrs199472730GRCh37Chr 11, 2594125: 2594125
118KCNQ1NM_000218.2(KCNQ1): c.830C> T (p.Ser277Leu)single nucleotide variantPathogenicrs199472730GRCh37Chr 11, 2594125: 2594125
119KCNQ1NM_000218.2(KCNQ1): c.839T> A (p.Val280Glu)single nucleotide variantPathogenicrs199473462GRCh37Chr 11, 2594134: 2594134
120KCNQ1NM_000218.2(KCNQ1): c.944A> G (p.Tyr315Cys)single nucleotide variantPathogenicrs74462309GRCh37Chr 11, 2604687: 2604687
121KCNQ1NM_000218.2(KCNQ1): c.946G> A (p.Gly316Arg)single nucleotide variantPathogenicrs104894255GRCh37Chr 11, 2604689: 2604689
122KCNQ1NM_000218.2(KCNQ1): c.949G> A (p.Asp317Asn)single nucleotide variantPathogenicrs199472751GRCh37Chr 11, 2604692: 2604692
123KCNQ1NM_000218.2(KCNQ1): c.954G> C (p.Lys318Asn)single nucleotide variantPathogenicrs199472752GRCh37Chr 11, 2604697: 2604697
124KCNQ1NM_000218.2(KCNQ1): c.964A> G (p.Thr322Ala)single nucleotide variantPathogenicrs199472754GRCh37Chr 11, 2604707: 2604707
125KCNQ1NM_000218.2(KCNQ1): c.965C> T (p.Thr322Met)single nucleotide variantLikely pathogenic, Pathogenicrs199472755GRCh37Chr 11, 2604708: 2604708
126KCNQ1NM_000218.2(KCNQ1): c.973G> A (p.Gly325Arg)single nucleotide variantPathogenicrs199472756GRCh37Chr 11, 2604716: 2604716
127KCNE2NM_172201.1(KCNE2): c.161T> C (p.Met54Thr)single nucleotide variantLikely pathogenic, Pathogenicrs74315447GRCh37Chr 21, 35742938: 35742938
128KCNE2NM_172201.1(KCNE2): c.79C> T (p.Arg27Cys)single nucleotide variantPathogenicrs74315449GRCh37Chr 21, 35742856: 35742856
129KCNQ1NM_000218.2(KCNQ1): c.1022C> G (p.Ala341Gly)single nucleotide variantPathogenicrs12720459GRCh37Chr 11, 2604765: 2604765
130KCNQ1NM_000218.2(KCNQ1): c.1031C> A (p.Ala344Glu)single nucleotide variantPathogenicrs199472763GRCh37Chr 11, 2604774: 2604774
131KCNQ1NM_000218.2(KCNQ1): c.1193A> G (p.Lys398Arg)single nucleotide variantPathogenicrs199472777GRCh37Chr 11, 2608864: 2608864
132KCNQ1NM_000218.2(KCNQ1): c.1343C> T (p.Pro448Leu)single nucleotide variantPathogenicrs12720449GRCh37Chr 11, 2610034: 2610034
133KCNQ1NM_000218.2(KCNQ1): c.1351C> T (p.Arg451Trp)single nucleotide variantPathogenicrs199472782GRCh37Chr 11, 2610042: 2610042
134KCNQ1NM_000218.2(KCNQ1): c.1553G> A (p.Arg518Gln)single nucleotide variantPathogenicrs145974930GRCh37Chr 11, 2790112: 2790112
135KCNQ1NM_000218.2(KCNQ1): c.1565A> C (p.Tyr522Ser)single nucleotide variantPathogenicrs199472789GRCh37Chr 11, 2790124: 2790124
136KCNQ1NM_000218.2(KCNQ1): c.1597C> T (p.Arg533Trp)single nucleotide variantPathogenicrs199472793GRCh37Chr 11, 2797196: 2797196
137KCNQ1NM_000218.2(KCNQ1): c.1616G> A (p.Arg539Gln)single nucleotide variantPathogenicrs199472794GRCh37Chr 11, 2797215: 2797215
138KCNQ1NM_000218.2(KCNQ1): c.1621G> A (p.Val541Ile)single nucleotide variantPathogenicrs199472796GRCh37Chr 11, 2797220: 2797220
139KCNQ1NM_000218.2(KCNQ1): c.1748G> A (p.Arg583His)single nucleotide variantPathogenicrs199473482GRCh37Chr 11, 2799221: 2799221
140NM_000218.2(KCNQ1): c.1799C> T (p.Thr600Met)single nucleotide variantPathogenicrs34516117GRCh37Chr 11, 2869001: 2869001
141NM_000218.2(KCNQ1): c.1903G> A (p.Gly635Arg)single nucleotide variantLikely pathogenic, Pathogenicrs199473484GRCh37Chr 11, 2869105: 2869105
142KCNQ1NM_000218.2(KCNQ1): c.401T> C (p.Leu134Pro)single nucleotide variantPathogenicrs199472685GRCh37Chr 11, 2549172: 2549172
143KCNQ1NM_000218.2(KCNQ1): c.484G> A (p.Val162Met)single nucleotide variantPathogenicrs199472692GRCh37Chr 11, 2591864: 2591864
144KCNQ1NM_000218.2(KCNQ1): c.550T> C (p.Tyr184His)single nucleotide variantPathogenicrs199473661GRCh37Chr 11, 2591930: 2591930
145KCNQ1NM_000218.2(KCNQ1): c.569G> T (p.Arg190Leu)single nucleotide variantPathogenicrs120074178GRCh37Chr 11, 2591949: 2591949
146KCNQ1NM_000218.2(KCNQ1): c.575G> A (p.Arg192His)single nucleotide variantPathogenicrs199472698GRCh37Chr 11, 2591955: 2591955
147KCNQ1NM_000218.2(KCNQ1): c.5C> T (p.Ala2Val)single nucleotide variantPathogenicrs199473442GRCh37Chr 11, 2466333: 2466333
148KCNQ1NM_000218.2(KCNQ1): c.608T> C (p.Leu203Pro)single nucleotide variantPathogenicrs199472823GRCh37Chr 11, 2592558: 2592558
149KCNQ1NM_000218.2(KCNQ1): c.724G> T (p.Asp242Tyr)single nucleotide variantPathogenicrs199472712GRCh37Chr 11, 2593283: 2593283
150KCNQ1NM_000218.2(KCNQ1): c.742T> C (p.Trp248Arg)single nucleotide variantPathogenicrs199473459GRCh37Chr 11, 2593301: 2593301
151KCNQ1NM_000218.2(KCNQ1): c.803T> G (p.Ile268Ser)single nucleotide variantPathogenicrs199472725GRCh37Chr 11, 2594098: 2594098
152KCNQ1NM_000218.2(KCNQ1): c.820A> G (p.Ile274Val)single nucleotide variantLikely pathogenic, Pathogenicrs199472728GRCh37Chr 11, 2594115: 2594115
153KCNQ1NM_000218.2(KCNQ1): c.850G> A (p.Glu284Lys)single nucleotide variantPathogenicrs199472734GRCh37Chr 11, 2594145: 2594145
154KCNQ1NM_000218.2(KCNQ1): c.875G> A (p.Gly292Asp)single nucleotide variantPathogenicrs199472736GRCh37Chr 11, 2594170: 2594170
155KCNQ1NM_000218.2(KCNQ1): c.877C> T (p.Arg293Cys)single nucleotide variantPathogenicrs199472737GRCh37Chr 11, 2594172: 2594172
156KCNQ1NM_000218.2(KCNQ1): c.905C> A (p.Ala302Glu)single nucleotide variantPathogenicrs193922365GRCh37Chr 11, 2594200: 2594200
157KCNQ1NM_000218.2(KCNQ1): c.958C> T (p.Pro320Ser)single nucleotide variantPathogenicrs199472753GRCh37Chr 11, 2604701: 2604701
158KCNH2NM_000238.3(KCNH2): c.1001C> T (p.Pro334Leu)single nucleotide variantPathogenicrs199472888GRCh37Chr 7, 150654506: 150654506
159KCNH2NM_000238.3(KCNH2): c.1262C> T (p.Thr421Met)single nucleotide variantPathogenicrs199472894GRCh37Chr 7, 150649808: 150649808
160KCNH2NM_000238.3(KCNH2): c.1264G> A (p.Ala422Thr)single nucleotide variantPathogenicrs199472895GRCh37Chr 7, 150649806: 150649806
161KCNH2NM_000238.3(KCNH2): c.128A> G (p.Tyr43Cys)single nucleotide variantPathogenicrs199472836GRCh37Chr 7, 150671978: 150671978
162KCNH2NM_000238.3(KCNH2): c.1352C> T (p.Pro451Leu)single nucleotide variantPathogenicrs199472902GRCh37Chr 7, 150649718: 150649718
163KCNH2NM_000238.3(KCNH2): c.1421C> T (p.Thr474Ile)single nucleotide variantPathogenicrs199472906GRCh37Chr 7, 150649649: 150649649
164KCNH2NM_000238.3(KCNH2): c.1501G> A (p.Asp501Asn)single nucleotide variantPathogenicrs199472912GRCh37Chr 7, 150649569: 150649569
165KCNH2NM_000238.3(KCNH2): c.1502A> G (p.Asp501Gly)single nucleotide variantPathogenicrs199473513GRCh37Chr 7, 150649568: 150649568
166KCNH2NM_000238.3(KCNH2): c.1600C> T (p.Arg534Cys)single nucleotide variantPathogenicrs199472916GRCh37Chr 7, 150648881: 150648881
167KCNH2NM_000238.3(KCNH2): c.1609C> T (p.Arg537Trp)single nucleotide variantPathogenicrs199472917GRCh37Chr 7, 150648872: 150648872
168KCNH2NM_000238.3(KCNH2): c.164C> T (p.Ser55Leu)single nucleotide variantPathogenicrs199472844GRCh37Chr 7, 150671942: 150671942
169KCNH2NM_000238.3(KCNH2): c.1655T> C (p.Leu552Ser)single nucleotide variantPathogenicrs199472918GRCh37Chr 7, 150648826: 150648826
170KCNH2NM_000238.3(KCNH2): c.1673C> A (p.Ala558Glu)single nucleotide variantPathogenicrs199472919GRCh37Chr 7, 150648808: 150648808
171KCNH2NM_000238.3(KCNH2): c.1681G> A (p.Ala561Thr)single nucleotide variantPathogenicrs199472921GRCh37Chr 7, 150648800: 150648800
172KCNH2NM_000238.3(KCNH2): c.1685A> G (p.His562Arg)single nucleotide variantPathogenicrs199472922GRCh37Chr 7, 150648796: 150648796
173KCNH2NM_000238.3(KCNH2): c.1714G> A (p.Gly572Ser)single nucleotide variantPathogenicrs9333649GRCh37Chr 7, 150648767: 150648767
174KCNH2NM_000238.3(KCNH2): c.1715G> T (p.Gly572Val)single nucleotide variantPathogenicrs199473423GRCh37Chr 7, 150648766: 150648766
175KCNH2NM_000238.3(KCNH2): c.173A> G (p.Glu58Gly)single nucleotide variantPathogenicrs199472847GRCh37Chr 7, 150671933: 150671933
176KCNH2NM_000238.3(KCNH2): c.1750G> A (p.Gly584Ser)single nucleotide variantPathogenicrs199473428GRCh37Chr 7, 150648731: 150648731
177KCNH2NM_000238.3(KCNH2): c.1750G> T (p.Gly584Cys)single nucleotide variantPathogenicrs199473428GRCh37Chr 7, 150648731: 150648731
178KCNH2NM_000238.3(KCNH2): c.1778T> C (p.Ile593Thr)single nucleotide variantPathogenicrs28928904GRCh37Chr 7, 150648703: 150648703
179KCNH2NM_000238.3(KCNH2): c.1787C> A (p.Pro596His)single nucleotide variantPathogenicrs199472933GRCh37Chr 7, 150648694: 150648694
180KCNH2NM_000238.3(KCNH2): c.1801G> A (p.Gly601Ser)single nucleotide variantPathogenicrs199472936GRCh37Chr 7, 150648680: 150648680
181KCNH2NM_000238.3(KCNH2): c.1810G> A (p.Gly604Ser)single nucleotide variantPathogenicrs199473522GRCh37Chr 7, 150648671: 150648671
182KCNH2NM_000238.3(KCNH2): c.1847A> G (p.Tyr616Cys)single nucleotide variantPathogenicrs199472946GRCh37Chr 7, 150648634: 150648634
183KCNH2NM_000238.3(KCNH2): c.1864C> T (p.Leu622Phe)single nucleotide variantPathogenicrs199473525GRCh37Chr 7, 150648617: 150648617
184KCNH2NM_000238.3(KCNH2): c.1885A> G (p.Asn629Asp)single nucleotide variantPathogenicrs199472956GRCh37Chr 7, 150648596: 150648596
185KCNH2NM_000238.3(KCNH2): c.1886A> G (p.Asn629Ser)single nucleotide variantPathogenicrs199472957GRCh37Chr 7, 150648595: 150648595
186KCNH2NM_000238.3(KCNH2): c.1894C> T (p.Pro632Ser)single nucleotide variantPathogenicrs199473527GRCh37Chr 7, 150648587: 150648587
187KCNH2NM_000238.3(KCNH2): c.1898A> G (p.Asn633Ser)single nucleotide variantPathogenicrs199472961GRCh37Chr 7, 150648583: 150648583
188KCNH2NM_000238.3(KCNH2): c.1933A> G (p.Met645Val)single nucleotide variantPathogenicrs199472974GRCh37Chr 7, 150648548: 150648548
189KCNH2NM_000238.3(KCNH2): c.1979C> T (p.Ser660Leu)single nucleotide variantPathogenicrs199472979GRCh37Chr 7, 150648175: 150648175
190KCNH2NM_000238.3(KCNH2): c.202T> C (p.Phe68Leu)single nucleotide variantLikely pathogenic, Pathogenicrs199473417GRCh37Chr 7, 150671904: 150671904
191KCNH2NM_000238.3(KCNH2): c.2078T> C (p.Leu693Pro)single nucleotide variantPathogenicrs199472983GRCh37Chr 7, 150648076: 150648076
192KCNH2NM_000238.3(KCNH2): c.209A> G (p.His70Arg)single nucleotide variantPathogenicrs199473419GRCh37Chr 7, 150671897: 150671897
193KCNH2NM_000238.3(KCNH2): c.211G> C (p.Gly71Arg)single nucleotide variantPathogenicrs199473420GRCh37Chr 7, 150671895: 150671895
194KCNH2NM_000238.3(KCNH2): c.2131A> G (p.Ile711Val)single nucleotide variantPathogenicrs199473532GRCh37Chr 7, 150648023: 150648023
195KCNH2NM_000238.3(KCNH2): c.215C> A (p.Pro72Gln)single nucleotide variantPathogenicrs199473421GRCh37Chr 7, 150671891: 150671891
196KCNH2NM_000238.3(KCNH2): c.215C> T (p.Pro72Leu)single nucleotide variantPathogenicrs199473421GRCh37Chr 7, 150671891: 150671891
197KCNH2NM_000238.3(KCNH2): c.221C> G (p.Thr74Arg)single nucleotide variantPathogenicrs199473422GRCh37Chr 7, 150671885: 150671885
198KCNH2NM_000238.3(KCNH2): c.2246G> T (p.Gly749Val)single nucleotide variantPathogenicrs199472989GRCh37Chr 7, 150647408: 150647408
199KCNH2NM_000238.3(KCNH2): c.2254C> T (p.Arg752Trp)single nucleotide variantPathogenicrs199472990GRCh37Chr 7, 150647400: 150647400
200KCNH2NM_000238.3(KCNH2): c.2320G> T (p.Asp774Tyr)single nucleotide variantPathogenicrs199472995GRCh37Chr 7, 150647334: 150647334
201KCNH2NM_000238.3(KCNH2): c.2362G> A (p.Glu788Lys)single nucleotide variantPathogenicrs199472997GRCh37Chr 7, 150647292: 150647292
202KCNH2NM_000238.3(KCNH2): c.2414T> C (p.Phe805Ser)single nucleotide variantPathogenicrs199472999GRCh37Chr 7, 150646122: 150646122
203KCNH2NM_000238.3(KCNH2): c.2414T> G (p.Phe805Cys)single nucleotide variantPathogenicrs199472999GRCh37Chr 7, 150646122: 150646122
204KCNH2NM_000238.3(KCNH2): c.2417G> A (p.Gly806Glu)single nucleotide variantPathogenicrs199473000GRCh37Chr 7, 150646119: 150646119
205KCNH2NM_000238.3(KCNH2): c.2467C> T (p.Arg823Trp)single nucleotide variantPathogenicrs199473538GRCh37Chr 7, 150646069: 150646069
206KCNH2NM_000238.3(KCNH2): c.2477C> T (p.Thr826Ile)single nucleotide variantPathogenicrs199473002GRCh37Chr 7, 150646059: 150646059
207KCNH2NM_000238.3(KCNH2): c.2509G> A (p.Asp837Asn)single nucleotide variantPathogenicrs199473005GRCh37Chr 7, 150646027: 150646027
208KCNH2NM_000238.3(KCNH2): c.2510A> G (p.Asp837Gly)single nucleotide variantPathogenicrs199473004GRCh37Chr 7, 150646026: 150646026
209KCNH2NM_000238.3(KCNH2): c.2536C> T (p.Pro846Ser)single nucleotide variantPathogenicrs199473006GRCh37Chr 7, 150646000: 150646000
210KCNH2NM_000238.3(KCNH2): c.2680C> T (p.Arg894Cys)single nucleotide variantPathogenicrs199473433GRCh37Chr 7, 150645544: 150645544
211KCNH2NM_000238.3(KCNH2): c.2681G> T (p.Arg894Leu)single nucleotide variantPathogenicrs199473668GRCh37Chr 7, 150645543: 150645543
212KCNH2NM_000238.3(KCNH2): c.2707G> A (p.Gly903Arg)single nucleotide variantPathogenicrs199473669GRCh37Chr 7, 150644952: 150644952
213KCNH2NM_000238.3(KCNH2): c.2717C> T (p.Ser906Leu)single nucleotide variantPathogenicrs199473435GRCh37Chr 7, 150644942: 150644942
214KCNH2NM_000238.3(KCNH2): c.2771G> A (p.Gly924Glu)single nucleotide variantPathogenicrs199473009GRCh37Chr 7, 150644888: 150644888
215KCNH2NM_000238.3(KCNH2): c.2810G> A (p.Ser937Asn)single nucleotide variantPathogenicrs199473540GRCh37Chr 7, 150644849: 150644849
216KCNH2NM_000238.3(KCNH2): c.281T> G (p.Val94Gly)single nucleotide variantPathogenicrs199472852GRCh37Chr 7, 150671825: 150671825
217KCNH2NM_000238.3(KCNH2): c.2843G> A (p.Arg948His)single nucleotide variantPathogenicrs199473011GRCh37Chr 7, 150644816: 150644816
218KCNH2NM_000238.3(KCNH2): c.2887C> A (p.Pro963Thr)single nucleotide variantPathogenicrs199473014GRCh37Chr 7, 150644772: 150644772
219KCNH2NM_000238.3(KCNH2): c.2987A> T (p.Asn996Ile)single nucleotide variantPathogenicrs199473018GRCh37Chr 7, 150644581: 150644581
220KCNH2NM_000238.3(KCNH2): c.299G> A (p.Arg100Gln)single nucleotide variantPathogenicrs199472855GRCh37Chr 7, 150671807: 150671807
221KCNH2NM_000238.3(KCNH2): c.301A> G (p.Lys101Glu)single nucleotide variantPathogenicrs199472856GRCh37Chr 7, 150671805: 150671805
222KCNH2NM_000238.3(KCNH2): c.3107G> A (p.Gly1036Asp)single nucleotide variantPathogenicrs199473022GRCh37Chr 7, 150644461: 150644461
223KCNH2NM_000238.3(KCNH2): c.3112G> A (p.Val1038Met)single nucleotide variantPathogenicrs199473544GRCh37Chr 7, 150644456: 150644456
224KCNH2NM_000238.3(KCNH2): c.3133C> T (p.Leu1045Phe)single nucleotide variantPathogenicrs199473025GRCh37Chr 7, 150644435: 150644435
225KCNH2NM_000238.3(KCNH2): c.3343A> G (p.Met1115Val)single nucleotide variantPathogenicrs199473546GRCh37Chr 7, 150642590: 150642590
226KCNH2NM_000238.3(KCNH2): c.343G> A (p.Val115Met)single nucleotide variantPathogenicrs150988911GRCh37Chr 7, 150656789: 150656789
227KCNH2NM_000238.3(KCNH2): c.422C> T (p.Pro141Leu)single nucleotide variantPathogenicrs199472864GRCh37Chr 7, 150656710: 150656710
228KCNH2NM_000238.3(KCNH2): c.775G> A (p.Asp259Asn)single nucleotide variantPathogenicrs199472876GRCh37Chr 7, 150655288: 150655288
229KCNH2NM_000238.3(KCNH2): c.889C> T (p.Pro297Ser)single nucleotide variantPathogenicrs199472882GRCh37Chr 7, 150655174: 150655174
230KCNH2NM_000238.3(KCNH2): c.916G> C (p.Gly306Arg)single nucleotide variantLikely pathogenic, Pathogenicrs199472884GRCh37Chr 7, 150655147: 150655147
231KCNH2NM_000238.3(KCNH2): c.916G> T (p.Gly306Trp)single nucleotide variantPathogenicrs199472884GRCh37Chr 7, 150655147: 150655147
232KCNH2NM_000238.3(KCNH2): c.92T> C (p.Ile31Thr)single nucleotide variantPathogenicrs199472833GRCh37Chr 7, 150672014: 150672014
233KCNH2NM_000238.3(KCNH2): c.934C> T (p.Arg312Cys)single nucleotide variantPathogenicrs199472885GRCh37Chr 7, 150654573: 150654573
234KCNJ2NM_000891.2(KCNJ2): c.200G> A (p.Arg67Gln)single nucleotide variantPathogenicrs199473368GRCh37Chr 17, 68171380: 68171380
235KCNJ2NM_000891.2(KCNJ2): c.224C> T (p.Thr75Met)single nucleotide variantPathogenicrs104894585GRCh37Chr 17, 68171404: 68171404
236KCNJ2NM_000891.2(KCNJ2): c.233A> G (p.Asp78Gly)single nucleotide variantPathogenicrs199473371GRCh37Chr 17, 68171413: 68171413
237KCNJ2NM_000891.2(KCNJ2): c.566G> T (p.Arg189Ile)single nucleotide variantPathogenicrs199473381GRCh37Chr 17, 68171746: 68171746
238KCNJ2NM_000891.2(KCNJ2): c.653G> A (p.Arg218Gln)single nucleotide variantPathogenicrs199473384GRCh37Chr 17, 68171833: 68171833
239KCNJ2NM_000891.2(KCNJ2): c.779G> C (p.Arg260Pro)single nucleotide variantPathogenicrs199473385GRCh37Chr 17, 68171959: 68171959
240KCNJ2NM_000891.2(KCNJ2): c.899G> A (p.Gly300Asp)single nucleotide variantPathogenicrs104894579GRCh37Chr 17, 68172079: 68172079
241ANK2NM_001148.4(ANK2): c.10708G> A (p.Glu3570Lys)single nucleotide variantLikely pathogenic, Pathogenicrs180843436GRCh37Chr 4, 114282005: 114282005
242ANK2NM_001148.4(ANK2): c.10858T> A (p.Trp3620Arg)single nucleotide variantPathogenicrs199473346GRCh37Chr 4, 114284595: 114284595
243KCNE2NM_172201.1(KCNE2): c.229C> T (p.Arg77Trp)single nucleotide variantPathogenicrs141423405GRCh37Chr 21, 35743006: 35743006
244KCNE2NM_172201.1(KCNE2): c.29C> T (p.Thr10Met)single nucleotide variantLikely pathogenic, Pathogenicrs199473648GRCh37Chr 21, 35742806: 35742806
245KCNE2NM_172201.1(KCNE2): c.80G> A (p.Arg27His)single nucleotide variantPathogenicrs148968498GRCh37Chr 21, 35742857: 35742857
246SCN5ANM_000335.4(SCN5A): c.1231G> A (p.Val411Met)single nucleotide variantPathogenicrs72549410GRCh37Chr 3, 38647549: 38647549
247SCN5ANM_198056.2(SCN5A): c.1567C> T (p.Arg523Cys)single nucleotide variantLikely pathogenic, Pathogenicrs199473119GRCh37Chr 3, 38645526: 38645526
248SCN5ANM_000335.4(SCN5A): c.1844G> A (p.Gly615Glu)single nucleotide variantLikely pathogenic, Pathogenicrs12720452GRCh37Chr 3, 38645249: 38645249
249SCN5ANM_000335.4(SCN5A): c.1855C> T (p.Leu619Phe)single nucleotide variantPathogenicrs199473133GRCh37Chr 3, 38645238: 38645238
250SCN5ANM_000335.4(SCN5A): c.5333C> T (p.Thr1778Met)single nucleotide variantPathogenicrs199473634GRCh37Chr 3, 38592527: 38592527
251GPD1LNM_015141.3(GPD1L): c.370A> G (p.Ile124Val)single nucleotide variantLikely pathogenic, Pathogenicrs72552293GRCh37Chr 3, 32181723: 32181723
252KCNJ2NM_000891.2(KCNJ2): c.212A> T (p.Asp71Val)single nucleotide variantPathogenicrs104894575GRCh37Chr 17, 68171392: 68171392
253KCNJ2NM_000891.2(KCNJ2): c.652C> T (p.Arg218Trp)single nucleotide variantPathogenicrs104894578GRCh37Chr 17, 68171832: 68171832
254KCNJ2NM_000891.2(KCNJ2): c.899G> T (p.Gly300Val)single nucleotide variantPathogenicrs104894579GRCh37Chr 17, 68172079: 68172079
255KCNJ2NM_000891.2(KCNJ2): c.199C> T (p.Arg67Trp)single nucleotide variantPathogenicrs104894580GRCh37Chr 17, 68171379: 68171379
256KCNJ2NM_000891.2(KCNJ2): c.557C> T (p.Pro186Leu)single nucleotide variantPathogenicrs104894581GRCh37Chr 17, 68171737: 68171737
257KCNJ2NM_000891.2(KCNJ2): c.904G> A (p.Val302Met)single nucleotide variantPathogenicrs104894582GRCh37Chr 17, 68172084: 68172084
258KCNJ2NM_000891.2(KCNJ2): c.646A> C (p.Asn216His)single nucleotide variantPathogenicrs104894583GRCh37Chr 17, 68171826: 68171826
259KCNJ2NM_000891.2(KCNJ2): c.224C> G (p.Thr75Arg)single nucleotide variantPathogenicrs104894585GRCh37Chr 17, 68171404: 68171404
260SCN5ANM_198056.2(SCN5A): c.4931G> A (p.Arg1644His)single nucleotide variantPathogenicrs28937316GRCh37Chr 3, 38592932: 38592932
261SCN5ANM_000335.4(SCN5A): c.3971A> G (p.Asn1324Ser)single nucleotide variantPathogenicrs28937317GRCh37Chr 3, 38601909: 38601909
262SCN5ANM_000335.4(SCN5A): c.5381A> G (p.Tyr1794Cys)single nucleotide variantPathogenicrs137854614GRCh37Chr 3, 38592479: 38592479
263SCN5ANM_000335.4(SCN5A): c.4865G> A (p.Arg1622Gln)single nucleotide variantPathogenicrs137854600GRCh37Chr 3, 38592995: 38592995
264SCN5ANM_198056.2(SCN5A): c.5350G> A (p.Glu1784Lys)single nucleotide variantPathogenicrs137854601GRCh37Chr 3, 38592513: 38592513
265SCN5ANM_198056.2(SCN5A): c.2989G> T (p.Ala997Ser)single nucleotide variantPathogenicrs137854609GRCh37Chr 3, 38622661: 38622661
266SCN5ANM_000335.4(SCN5A): c.5474G> A (p.Arg1825His)single nucleotide variantPathogenicrs137854610GRCh37Chr 3, 38592386: 38592386
267SCN5ANM_000335.4(SCN5A): c.3157G> A (p.Glu1053Lys)single nucleotide variantPathogenicrs137854617GRCh37Chr 3, 38622493: 38622493

Expression for genes affiliated with Long Qt Syndrome

About this section
Search GEO for disease gene expression data for Long Qt Syndrome.

Pathways for genes affiliated with Long Qt Syndrome

About this section

Pathways related to Long Qt Syndrome according to GeneCards Suite gene sharing:

(show top 50)    (show all 56)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.1ANK2, SCN4B, SCN5A
29.9CALM1, CALM2, CALM3
39.9CALM1, CALM2, CALM3
49.9CALM1, CALM2, CALM3
59.9CALM1, CALM2, CALM3
69.9CALM1, CALM2, CALM3
7
p38 MAPK signaling pathway (Pathway Interaction Database)
Show member pathways
9.9CALM1, CALM2, CALM3
89.9CALM1, CALM2, CALM3
99.9CALM1, CALM2, CALM3
109.9CALM1, CALM2, CALM3
119.9CALM1, CALM2, CALM3
129.9CALM1, CALM2, CALM3
13
Show member pathways
9.9CALM1, CALM2, CALM3
14
Show member pathways
9.9CALM1, CALM2, CALM3
159.9CALM1, CALM2, CALM3
16
Show member pathways
9.9CALM1, CALM2, CALM3
17
Show member pathways
9.9CALM1, CALM2, CALM3
189.9CALM1, CALM2, CALM3
19
Show member pathways
9.9CALM1, CALM2, CALM3
209.9CALM1, CALM2, CALM3
219.9CALM1, CALM2, CALM3
229.9CALM1, CALM2, CALM3
239.9CALM1, CALM2, CALM3
249.9CALM1, CALM2, CALM3
259.9CALM1, CALM2, CALM3
26
Show member pathways
9.8CACNA1C, CALM1, CALM2, CALM3
27
Show member pathways
9.8CACNA1C, CALM1, CALM2, CALM3
28
Show member pathways
9.8CACNA1C, CALM1, CALM2, CALM3
29
Show member pathways
9.8CACNA1C, CALM1, CALM2, CALM3
30
Show member pathways
9.8CACNA1C, CALM1, CALM2, CALM3
31
Show member pathways
9.8CALM1, CALM2, CALM3, CAV3
32
Show member pathways
9.8AKAP9, CALM1, CALM2, CALM3
339.7CACNA1C, CALM1, CALM2, CALM3, KCNJ2
349.7CACNA1C, CALM1, CALM2, CALM3, RYR2
35
Show member pathways
9.7CACNA1C, CALM1, CALM2, CALM3, RYR2
36
Show member pathways
9.7CACNA1C, CALM1, CALM2, CALM3, RYR2
37
Show member pathways
9.7AKAP9, CACNA1C, CALM1, CALM2, CALM3
38
Show member pathways
9.6CALM1, CALM2, CALM3, KCNE2, KCNJ2, KCNQ1
399.5CAV3, KCNH2, KCNQ1, RYR2, SCN4B, SCN5A
40
Show member pathways
9.5KCND2, KCND3, KCNH2, KCNJ2, KCNJ5, KCNQ1
41
Show member pathways
9.5CACNA1C, CALM1, CALM2, CALM3, RYR2, SNTA1
42
Show member pathways
9.5CACNA1C, CALM1, CALM2, CALM3, KCNJ5, RYR2
43
Show member pathways
9.4CACNA1C, CALM1, CALM2, CALM3, KCNJ5, SCN4B
44
Show member pathways
9.4CACNA1C, CALM1, CALM2, CALM3, KCNJ2, KCNJ5
45
Show member pathways
9.3AKAP9, ANK2, CACNA1C, CALM1, CALM2, CALM3
46
Show member pathways
9.2CACNA1C, CALM1, CALM2, CALM3, KCNE1, KCNQ1
47
Show member pathways
9.0CACNA1C, CALM1, CALM2, CALM3, KCND2, KCNJ2
48
Show member pathways
8.8AKAP9, CALM1, CALM2, CALM3, KCND2, KCND3
498.8ANK2, CACNA1C, KCND3, KCNE1, KCNE2, KCNH2
508.5AKAP9, CACNA1C, CALM1, CALM2, CALM3, KCND2

GO Terms for genes affiliated with Long Qt Syndrome

About this section

Cellular components related to Long Qt Syndrome according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1voltage-gated sodium channel complexGO:000151810.9SCN4B, SCN5A
2spindle microtubuleGO:000587610.5CALM1, CALM2, CALM3
3sarcomereGO:003001710.4CALM1, CALM2, CALM3, RYR2
4calcium channel complexGO:003470410.4CALM1, CALM2, CALM3, RYR2
5spindle poleGO:000092210.4CALM1, CALM2, CALM3
6intercalated discGO:001470410.4ANK2, CAV3, KCNJ2, SCN4B, SCN5A
7vesicleGO:003198210.3CALM1, CALM2, CALM3, CAV3
8T-tubuleGO:003031510.3ANK2, CACNA1C, CAV3, KCNJ2, KCNJ5, SCN5A
9cell surfaceGO:00099869.7CAV3, KCNE1, KCNE2, KCNH2, SCN5A
10sarcolemmaGO:00423839.6ANK2, CACNA1C, CAV3, KCND3, SCN5A, SNTA1
11voltage-gated potassium channel complexGO:00080769.5AKAP9, KCND2, KCND3, KCNE1, KCNE2, KCNH2
12Z discGO:00300189.4ANK2, CACNA1C, CAV3, KCNE1, RYR2, SCN5A
13membraneGO:00160209.1CACNA1C, CAV3, KCND2, KCND3, KCNE1, KCNE2
14plasma membraneGO:00058867.7ALG10B, ANK2, CACNA1C, CALM1, CALM2, CALM3

Biological processes related to Long Qt Syndrome according to GeneCards Suite gene sharing:

(show top 50)    (show all 89)
idNameGO IDScoreTop Affiliating Genes
1AV node cell action potentialGO:008601611.0SCN4B, SCN5A
2membrane depolarization during SA node cell action potentialGO:008604610.9ANK2, SCN5A
3regulation of SA node cell action potentialGO:009890710.9ANK2, RYR2
4potassium ion export across plasma membraneGO:009762310.9KCNH2, KCNQ1
5regulation of calcium ion transmembrane transporter activityGO:190101910.9ANK2, CAV3
6regulation of cardiac muscle cell contractionGO:008600410.7ANK2, KCNJ2, SCN5A
7membrane depolarization during cardiac muscle cell action potentialGO:008601210.7KCNJ2, SCN4B, SCN5A
8positive regulation of potassium ion transmembrane transportGO:190138110.7KCNE1, KCNH2, KCNJ2, KCNQ1
9membrane depolarization during action potentialGO:008601010.6CACNA1C, KCNH2, SCN5A
10membrane repolarizationGO:008600910.6KCND3, KCNE1, KCNE2
11membrane repolarization during cardiac muscle cell action potentialGO:008601310.6KCNE1, KCNH2, KCNJ2, KCNQ1
12membrane repolarization during action potentialGO:008601110.5KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1
13positive regulation of heart rateGO:001046010.5KCNQ1, RYR2, SCN5A
14negative regulation of peptidyl-threonine phosphorylationGO:001080110.5CALM1, CALM2, CALM3
15positive regulation of cyclic nucleotide metabolic processGO:003080110.5CALM1, CALM2, CALM3
16positive regulation of protein autophosphorylationGO:003195410.5CALM1, CALM2, CALM3
17regulation of cytokinesisGO:003246510.5CALM1, CALM2, CALM3
18positive regulation of protein dephosphorylationGO:003530710.5CALM1, CALM2, CALM3
19positive regulation of cyclic-nucleotide phosphodiesterase activityGO:005134310.5CALM1, CALM2, CALM3
20positive regulation of ryanodine-sensitive calcium-release channel activityGO:006031610.5CALM1, CALM2, CALM3
21regulation of high voltage-gated calcium channel activityGO:190184110.5CALM1, CALM2, CALM3
22regulation of cell communication by electrical coupling involved in cardiac conductionGO:190184410.5CALM1, CALM2, CALM3
23cardiac muscle cell action potential involved in contractionGO:008600210.5KCNE1, KCNE2, KCNJ2, SCN4B, SCN5A
24negative regulation of ryanodine-sensitive calcium-release channel activityGO:006031510.5CALM1, CALM2, CALM3
25potassium ion exportGO:007143510.5KCND3, KCNE1, KCNE2, KCNH2, KCNQ1
26positive regulation of phosphoprotein phosphatase activityGO:003251610.5CALM1, CALM2, CALM3
27positive regulation of peptidyl-threonine phosphorylationGO:001080010.4CALM1, CALM2, CALM3
28response to corticosteroneGO:005141210.4CALM1, CALM2, CALM3
29regulation of membrane repolarizationGO:006030610.4AKAP9, KCNE2, KCNH2, KCNJ2, KCNQ1
30glycogen catabolic processGO:000598010.4CALM1, CALM2, CALM3
31detection of calcium ionGO:000551310.3CALM1, CALM2, CALM3, RYR2
32nitric oxide metabolic processGO:004620910.3CALM1, CALM2, CALM3
33regulation of nitric-oxide synthase activityGO:005099910.3CALM1, CALM2, CALM3
34positive regulation of nitric-oxide synthase activityGO:005100010.3CALM1, CALM2, CALM3
35potassium ion transmembrane transportGO:007180510.3KCND2, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1
36regulation of potassium ion transmembrane transportGO:190137910.2KCNE1, KCNE2, KCNH2
37muscle contractionGO:000693610.2CALM1, CALM2, CALM3, SNTA1
38regulation of ion transmembrane transportGO:003476510.1CACNA1C, KCND2, KCND3, KCNJ5, SCN5A
39regulation of cardiac muscle contractionGO:005511710.1ANK2, CALM1, CALM2, CALM3, CAV3, RYR2
40ventricular cardiac muscle cell action potentialGO:008600510.0ANK2, CAV3, KCNE1, KCNE2, KCNH2, KCNQ1
41regulation of heart rate by cardiac conductionGO:00860919.9AKAP9, ANK2, KCNE1, KCNE2, KCNH2, KCNJ2
42regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumGO:00108809.8CALM1, CALM2, CALM3
43transmembrane transportGO:00550859.8CACNA1C, KCND2, KCND3, KCNH2, KCNQ1, RYR2
44regulation of ventricular cardiac muscle cell membrane repolarizationGO:00603079.8AKAP9, ANK2, CAV3, KCNE1, KCNE2, KCNH2
45cardiac muscle contractionGO:00600489.7ANK2, KCNH2, KCNQ1, RYR2, SCN4B, SCN5A
46ion transportGO:00068119.6CACNA1C, KCND2, KCND3, KCNE1, KCNE2, KCNH2
47axon guidanceGO:00074119.5AKAP9, ANK2, CACNA1C, CALM1, CALM2, CALM3
48regulation of heart rateGO:00020279.3ANK2, CALM1, CALM2, CALM3, CAV3, RYR2
49regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ionGO:00108819.2ANK2, CACNA1C, CALM1, CALM2, CALM3, RYR2
50synaptic transmissionGO:00072688.9AKAP9, CACNA1C, CALM1, CALM2, CALM3, KCND2

Molecular functions related to Long Qt Syndrome according to GeneCards Suite gene sharing:

(show all 32)
idNameGO IDScoreTop Affiliating Genes
1protein kinase A catalytic subunit bindingGO:003423611.0KCNQ1, RYR2
2voltage-gated sodium channel activity involved in cardiac muscle cell action potentialGO:008600611.0SCN4B, SCN5A
3A-type (transient outward) potassium channel activityGO:000525010.9KCND2, KCND3
4protein kinase A regulatory subunit bindingGO:003423710.8AKAP9, KCNQ1, RYR2
5voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarizationGO:008600810.8KCNE1, KCNH2, KCNJ2, KCNQ1
6sodium channel regulator activityGO:001708010.8CAV3, SCN4B, SNTA1
7voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationGO:190228210.7KCNE1, KCNE2, KCNH2, KCNQ1
8scaffold protein bindingGO:009711010.7KCNH2, KCNQ1, SCN5A
9inward rectifier potassium channel activityGO:000524210.7KCNE2, KCNH2, KCNJ2, KCNJ5
10nitric-oxide synthase regulator activityGO:003023510.6CALM1, CALM2, CALM3
11titin bindingGO:003143210.6CALM1, CALM2, CALM3
12type 3 metabotropic glutamate receptor bindingGO:003180010.6CALM1, CALM2, CALM3
13N-terminal myristoylation domain bindingGO:003199710.6CALM1, CALM2, CALM3
14protein phosphatase activator activityGO:007254210.6CALM1, CALM2, CALM3
15protein serine/threonine kinase activator activityGO:004353910.6CALM1, CALM2, CALM3
16thioesterase bindingGO:003199610.6CALM1, CALM2, CALM3
17adenylate cyclase bindingGO:000817910.6CALM1, CALM2, CALM3
18calcium-dependent protein bindingGO:004830610.6CALM1, CALM2, CALM3
19phosphatidylinositol 3-kinase bindingGO:004354810.5CALM1, CALM2, CALM3
20voltage-gated potassium channel activityGO:000524910.5KCND2, KCNE1, KCNE2, KCNH2, KCNQ1
21calmodulin bindingGO:000551610.4CACNA1C, KCNQ1, RYR2, SCN5A, SNTA1
22delayed rectifier potassium channel activityGO:000525110.3KCND2, KCND3, KCNE1, KCNE2, KCNH2, KCNQ1
23potassium channel regulator activityGO:001545910.2AKAP9, ANK2, KCNE1, KCNE2
24enzyme bindingGO:001989910.2ANK2, CACNA1C, CAV3, RYR2, SCN5A
25protein kinase bindingGO:001990110.1ANK2, CALM1, CALM2, CALM3, RYR2, SCN5A
26phospholipase bindingGO:004327410.1CALM1, CALM2, CALM3
27protein domain specific bindingGO:001990410.1CACNA1C, CALM1, CALM2, CALM3, SCN5A
28ion channel activityGO:000521610.1CACNA1C, KCND2, KCND3, KCNH2, KCNQ1, RYR2
29kinase activityGO:00163019.8AKAP9, CALM1, CALM2, CALM3
30nitric-oxide synthase bindingGO:00509989.2CALM1, CALM2, CALM3, CAV3, SCN5A, SNTA1
31ion channel bindingGO:00443259.0AKAP9, ANK2, CALM1, CALM2, CALM3, CAV3
32protein bindingGO:00055157.6AKAP9, ANK2, CACNA1C, CALM1, CALM2, CALM3

Sources for Long Qt Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet